Movatterモバイル変換


[0]ホーム

URL:


Skip directly to site contentSkip directly to page optionsSkip directly to A-Z linkSkip directly to A-Z linkSkip directly to A-Z link
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting PeopleCenters for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
×
×
×
Emerging Infectious Disease journalISSN: 1080-6059

Articles fromEmerging Infectious Diseases

Synopses

Retrospective Analysis of HistoricalListeria monocytogenes Clinical Isolates, New York, USA, 2000–2021 [PDF - 1.37 MB - 10 pages]
H. Samut et al.

We used whole-genome sequencing data to investigate historicalListeria monocytogenes clinical (n = 1,046) and nonclinical (n = 1,325) isolates from New York, USA. Applying a threshold of<20 single-nucleotide polymorphism differences for single-linkage clustering, 321 clinical isolates clustered into 85 clusters ranging from 2–33 isolates per cluster. Fourteen clusters included isolates with outbreak codes (4 clusters with New York codes and 10 with multistate codes). Three New York outbreak codes were assigned to isolates that were genetically highly related and from cases <2 months apart. Fifteen clusters included isolates that were obtained >10 years apart; 33 clusters included isolates from the same or contiguous counties. Seventeen clusters included food and environmental isolates highly related to clinical isolates. These findings suggest that some listeriosis clusters can be local and span a long period, demonstrating the importance of investigating small, localized listeriosis cases with closely related isolates, even over long timeframes.

EIDSamut H, Mendez-Vallellanes DV, Hoyt H, Wirth SE, Mingle L, Sauders BD, et al. Retrospective Analysis of Historical Listeria monocytogenes Clinical Isolates, New York, USA, 2000–2021. Emerg Infect Dis. 2025;31(10):1883-1892. https://doi.org/10.3201/eid3110.241876
AMASamut H, Mendez-Vallellanes DV, Hoyt H, et al. Retrospective Analysis of Historical Listeria monocytogenes Clinical Isolates, New York, USA, 2000–2021.Emerging Infectious Diseases. 2025;31(10):1883-1892. doi:10.3201/eid3110.241876.
APASamut, H., Mendez-Vallellanes, D. V., Hoyt, H., Wirth, S. E., Mingle, L., Sauders, B. D....Orsi, R. H. (2025). Retrospective Analysis of Historical Listeria monocytogenes Clinical Isolates, New York, USA, 2000–2021.Emerging Infectious Diseases,31(10), 1883-1892. https://doi.org/10.3201/eid3110.241876.

Organ Donor Transmission ofRickettsia typhi to Kidney Transplant Recipients, Texas, USA, 2024 [PDF - 1.79 MB - 8 pages]
J. C. Jones et al.

Murine typhus, a fleaborne disease caused by the bacteriumRickettsia typhi, is found throughout temperate and tropical regions of the world. Transmission ofR. typhi to humans involves several species of fleas, and most infections result from direct inoculation ofR. typhi–infected flea feces into abrasions in the skin. We describe the transmission ofR. typhi from an organ donor in Texas, USA, to 2 kidney transplant recipients. The donor and 1 recipient died from the infection. The occurrence ofR. typhi transmission via transplantation is a harbinger for the reemergence of murine typhus in some of the most densely populated metropolitan areas of the United States. Our findings reinforce the need to improve healthcare provider and public awareness of this life-threatening but treatable infection.

EIDJones JC, García OG, Villalba JA, Hinojosa R, Taylor ML, Annambhotla P, et al. Organ Donor Transmission of Rickettsia typhi to Kidney Transplant Recipients, Texas, USA, 2024. Emerg Infect Dis. 2025;31(10):1893-1900. https://doi.org/10.3201/eid3110.250961
AMAJones JC, García OG, Villalba JA, et al. Organ Donor Transmission of Rickettsia typhi to Kidney Transplant Recipients, Texas, USA, 2024.Emerging Infectious Diseases. 2025;31(10):1893-1900. doi:10.3201/eid3110.250961.
APAJones, J. C., García, O. G., Villalba, J. A., Hinojosa, R., Taylor, M. L., Annambhotla, P....Paddock, C. D. (2025). Organ Donor Transmission of Rickettsia typhi to Kidney Transplant Recipients, Texas, USA, 2024.Emerging Infectious Diseases,31(10), 1893-1900. https://doi.org/10.3201/eid3110.250961.
Research

Medscape CME Activity
Recent Systemic Antifungal Exposure and NonsusceptibleCandida in Hospitalized Patients, South Africa, 2012–2017 [PDF - 1.11 MB - 11 pages]
C. Rabault et al.

Candida bloodstream infections, and their increasing antifungal resistance, are a global concern. In this cross-sectional study, we analyzed 2,443 culture-confirmed candidemia cases reported in South Africa during 2012–2017 to assess the effect of previous antifungal exposure on nonsusceptibleCandida infection. We classified cases by species resistance profile and patient’s antifungal use within 14 days before infection. We found that 48% of cases were caused by nonsusceptible species, and 20% of patients had prior antifungal exposure, mainly to fluconazole. In patients >90 days of age, prior antifungal use was significantly associated with nonsusceptibleCandida bloodstream infection (adjusted OR 2.02, 95% CI 1.43–2.87; p<0.001), with species-specific effects. No such association was found in neonates and young infants, for whom hospital transmission appeared more influential. Our findings underscore the need for targeted antifungal stewardship and enhanced infection prevention to mitigate antifungal resistance in South Africa.

EIDRabault C, Shuping L, Mpembe R, Quan V, Lanternier F, Lortholary O, et al. Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012–2017. Emerg Infect Dis. 2025;31(10):1901-1911. https://doi.org/10.3201/eid3110.250359
AMARabault C, Shuping L, Mpembe R, et al. Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012–2017.Emerging Infectious Diseases. 2025;31(10):1901-1911. doi:10.3201/eid3110.250359.
APARabault, C., Shuping, L., Mpembe, R., Quan, V., Lanternier, F., Lortholary, O....Govender, N. P. (2025). Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012–2017.Emerging Infectious Diseases,31(10), 1901-1911. https://doi.org/10.3201/eid3110.250359.

Medscape CME Activity
Reptile Exposure in Human Salmonellosis Cases andSalmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022 [PDF - 1.72 MB - 10 pages]
K. Paphitis et al.

Reptile-associated outbreaks of humanSalmonella infections are increasing in Canada, coinciding with a rise in the popularity of reptiles as pets. We conducted a retrospective analysis of surveillance data for humanSalmonella case-patients in Ontario during 2015–2022. We compared serotypes and reptile types for those reporting domestic reptile or amphibian exposure with veterinarySalmonella isolates reported during the same period. Case-patients commonly reported contact with reptile types from whichSalmonella was most frequently isolated. Some serotypes from human case-patients were closely associated with contact with specific reptile types, includingSalmonella Paratyphi B biovar Java (Salmonella Paratyphi B variant L (+) tartrate +) with snakes,Salmonella Agbeni with turtles, andSalmonella Cotham,Salmonella Chester, andSalmonella Tennessee with bearded dragons.Salmonella was most likely to be reported from reptiles fed a carnivorous diet. Education of reptile owners could help promote proper veterinary care and reduce transmission of zoonotic infections.

EIDPaphitis K, Reid A, Golightly HR, Adams JA, Corbeil A, Majury A, et al. Reptile Exposure in Human Salmonellosis Cases and Salmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022. Emerg Infect Dis. 2025;31(10):1912-1921. https://doi.org/10.3201/eid3110.241803
AMAPaphitis K, Reid A, Golightly HR, et al. Reptile Exposure in Human Salmonellosis Cases and Salmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022.Emerging Infectious Diseases. 2025;31(10):1912-1921. doi:10.3201/eid3110.241803.
APAPaphitis, K., Reid, A., Golightly, H. R., Adams, J. A., Corbeil, A., Majury, A....McClinchey, H. (2025). Reptile Exposure in Human Salmonellosis Cases and Salmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022.Emerging Infectious Diseases,31(10), 1912-1921. https://doi.org/10.3201/eid3110.241803.

Comparative Epidemiology ofSalmonella entericaSerovers Paratyphi A and Typhi Causing Enteric Fever, Bangladesh, 2018–2020 [PDF - 2.36 MB - 13 pages]
S. Rahman et al.

Enteric fever remains a public health challenge. We analyzed data from a cluster-randomized Vi-tetanus toxoid conjugate vaccine trial to compare the epidemiology betweenSalmonella enterica serovars Paratyphi A, which causes paratyphoid fever, and Typhi, which causes typhoid fever. The overall incidence rate of paratyphoid fever was 27 (95% CI 23–32)/100,000 person-years (PY) and of typhoid fever was 216 (95% CI 198–236)/100,000 PY. We observed the highest incidence for both diseases in children 2–4 years of age: 72 (95% CI 41–117)/100,000 PY for paratyphoid and 887 (95% CI 715–1,088)/100,000 PY for typhoid. Lack of private toilets and safe drinking water were associated with both diseases. Prevalence of multidrug resistance was significantly higher inSalmonella Typhi (20.2%) than inSalmonella Paratyphi A (0.8%) (p<0.001). Our data suggest that integrated control measures targeting water, sanitation, and hygiene measures and bivalent vaccine targeting both pathogens are promising strategies to control both diseases.

EIDRahman S, Firoj M, Park S, Khanam F, Agampodi S, Haile K, et al. Comparative Epidemiology of Salmonella enterica Serovers Paratyphi A and Typhi Causing Enteric Fever, Bangladesh, 2018–2020. Emerg Infect Dis. 2025;31(10):1922-1934. https://doi.org/10.3201/eid3110.241601
AMARahman S, Firoj M, Park S, et al. Comparative Epidemiology of Salmonella enterica Serovers Paratyphi A and Typhi Causing Enteric Fever, Bangladesh, 2018–2020.Emerging Infectious Diseases. 2025;31(10):1922-1934. doi:10.3201/eid3110.241601.
APARahman, S., Firoj, M., Park, S., Khanam, F., Agampodi, S., Haile, K....Clemens, J. D. (2025). Comparative Epidemiology of Salmonella enterica Serovers Paratyphi A and Typhi Causing Enteric Fever, Bangladesh, 2018–2020.Emerging Infectious Diseases,31(10), 1922-1934. https://doi.org/10.3201/eid3110.241601.

Prolonged Monkeypox Virus Infections, California, USA, May 2022–August 2024 [PDF - 468 KB - 7 pages]
S. Schildhauer et al.

Monkeypox virus (MPXV) infection typically lasts 14–28 days. Prolonged MPXV infection, in which symptoms or test positivity last>28 days, has been documented but not fully characterized. We used the California Department of Public Health (California, USA) mpox registry to compare prolonged (>28 days) and nonprolonged (<28 days) mpox cases by demographics, HIV status, and JYNNEOS vaccination status. Of 6,469 cases, 82 (1.3%) were prolonged. Persons with prolonged MPXV infections were more likely to be Black or African American (prolonged, 20.7%, vs. nonprolonged, 11.6%) and to have HIV (prolonged, 61.0%, vs. nonprolonged, 39.9%). Among persons with HIV, prolonged infections were more likely among those with lower (<200) CD4 counts (prolonged, 10.0%, vs. nonprolonged, 3.9%) or not engaged in HIV care (prolonged, 46.0%, vs. nonprolonged, 18.1%). No prolonged infections occurred in persons who received 2 JYNNEOS vaccine doses. Groups disproportionately affected by prolonged mpox should be prioritized for mpox vaccine education and outreach.

EIDSchildhauer S, Saadeh K, Snyder RE, Tang EC, Chapman E, Sykes DA, et al. Prolonged Monkeypox Virus Infections, California, USA, May 2022–August 2024. Emerg Infect Dis. 2025;31(10):1935-1941. https://doi.org/10.3201/eid3110.250507
AMASchildhauer S, Saadeh K, Snyder RE, et al. Prolonged Monkeypox Virus Infections, California, USA, May 2022–August 2024.Emerging Infectious Diseases. 2025;31(10):1935-1941. doi:10.3201/eid3110.250507.
APASchildhauer, S., Saadeh, K., Snyder, R. E., Tang, E. C., Chapman, E., Sykes, D. A....Johnson, K. A. (2025). Prolonged Monkeypox Virus Infections, California, USA, May 2022–August 2024.Emerging Infectious Diseases,31(10), 1935-1941. https://doi.org/10.3201/eid3110.250507.

Differences in COVID-19 Fatality Rates among Ethnic Groups, Hawaii, USA, 2020–2022 [PDF - 1.39 MB - 8 pages]
G. Devendra et al.

Asian American, Native Hawaiian, and Pacific Islander populations have been underrepresented in research on COVID-19 outcomes. We conducted a cross-sectional study of 5,494 electronic medical records of patients in a large tertiary care health system in the ethnically diverse state of Hawaii, USA. We compared fatality rates for hospitalized patients on the basis of race or ethnicity, age, vaccination status, and sequential organ failure assessment (SOFA) score at admission. Fatality rates varied between racial and ethnic groups but were associated with increasing age across all groups. Fatality rates were closely associated with increasing SOFA score and were inversely associated with the number of COVID-19 vaccinations received. We found that Asian and Pacific Islander groups experienced higher rates of in-hospital death and that death was strongly associated with increased age and SOFA score and with<1 COVID-19 vaccination. Clinicians should be aware of these outcomes when treating COVID-19 patients from these ethnic groups.

EIDDevendra G, Chai M, Sumida E, Chen R, Gozun M, Chow D, et al. Differences in COVID-19 Fatality Rates among Ethnic Groups, Hawaii, USA, 2020–2022. Emerg Infect Dis. 2025;31(10):1942-1949. https://doi.org/10.3201/eid3110.241070
AMADevendra G, Chai M, Sumida E, et al. Differences in COVID-19 Fatality Rates among Ethnic Groups, Hawaii, USA, 2020–2022.Emerging Infectious Diseases. 2025;31(10):1942-1949. doi:10.3201/eid3110.241070.
APADevendra, G., Chai, M., Sumida, E., Chen, R., Gozun, M., Chow, D....Miller, F. (2025). Differences in COVID-19 Fatality Rates among Ethnic Groups, Hawaii, USA, 2020–2022.Emerging Infectious Diseases,31(10), 1942-1949. https://doi.org/10.3201/eid3110.241070.

Effect of Seasonal Influenza Vaccines on Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Ferrets [PDF - 2.59 MB - 11 pages]
X. Sun et al.

Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b viruses have infected >1,000 herds of dairy cattle and hundreds of poultry flocks in the United States since the beginning of 2024. Seventy human cases have been reported during that period, mainly through occupational exposure. Although prior influenza A(H1N1)pdm09 virus infection has been shown to confer protection against influenza A(H5N1) clade 2.3.4.4b virus infection in the ferret model, it remains unclear if influenza vaccines, known to elicit a less potent and narrower cross-reactive immune response, can achieve a similar effect. In this article, we demonstrate that immunization with commercially available human seasonal influenza vaccines also confers partial protection against disease caused by H5N1 clade 2.3.4.4b virus in ferrets, which is partially associated with the presence of cross-reactive antibodies targeting H5N1 virus antigens.

EIDSun X, Subbiah J, Belser JA, Brock N, Gansebom S, Li Z, et al. Effect of Seasonal Influenza Vaccines on Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Ferrets. Emerg Infect Dis. 2025;31(10):1950-1960. https://doi.org/10.3201/eid3110.250668
AMASun X, Subbiah J, Belser JA, et al. Effect of Seasonal Influenza Vaccines on Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Ferrets.Emerging Infectious Diseases. 2025;31(10):1950-1960. doi:10.3201/eid3110.250668.
APASun, X., Subbiah, J., Belser, J. A., Brock, N., Gansebom, S., Li, Z....York, I. A. (2025). Effect of Seasonal Influenza Vaccines on Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Ferrets.Emerging Infectious Diseases,31(10), 1950-1960. https://doi.org/10.3201/eid3110.250668.

Spotted Fever Group Rickettsioses among Hospitalized Patients and Circulation ofRickettsia in Ticks, Kazakhstan, 2019 [PDF - 520 KB - 8 pages]
Y. V. Bumburidi et al.

Testing for spotted fever group rickettsioses (SFGR) and the criteria for identifying suspected patients are not routinely used in Kazakhstan. In 2019, we performed a cross-sectional study in 6 sentinel hospitals in the Pavlodar region. We tested 105 hospitalized patients with SFGR-like symptoms by using PCR or indirect immunofluorescence antibody assay and identified 62 cases of SFGR. Most (78%) cases of disease were caused byRickettsia sibirica andR. raoultii. Cutaneous signs (eschar or rash) were found in 87% of SFGR patients; 79% had a rash, 48% had an eschar, and 13% had neither. Testing of suspected rickettsia cases resulted in a 27% increase in laboratory-detected SFGR over the mean of the previous 3 years (62 vs. 49). Broadening the case definition by including fever, headache, or myalgia and expanding routine testing for suspected cases of SFGR could contribute to improved case detection and earlier treatment.

EIDBumburidi YV, Berezovskiy DV, Zhakipbayeva BT, Horth RZ, Millman AJ, Nicholson WL, et al. Spotted Fever Group Rickettsioses among Hospitalized Patients and Circulation of Rickettsia in Ticks, Kazakhstan, 2019. Emerg Infect Dis. 2025;31(10):1961-1968. https://doi.org/10.3201/eid3110.250037
AMABumburidi YV, Berezovskiy DV, Zhakipbayeva BT, et al. Spotted Fever Group Rickettsioses among Hospitalized Patients and Circulation of Rickettsia in Ticks, Kazakhstan, 2019.Emerging Infectious Diseases. 2025;31(10):1961-1968. doi:10.3201/eid3110.250037.
APABumburidi, Y. V., Berezovskiy, D. V., Zhakipbayeva, B. T., Horth, R. Z., Millman, A. J., Nicholson, W. L....Shapiyeva, Z. (2025). Spotted Fever Group Rickettsioses among Hospitalized Patients and Circulation of Rickettsia in Ticks, Kazakhstan, 2019.Emerging Infectious Diseases,31(10), 1961-1968. https://doi.org/10.3201/eid3110.250037.

Multidrug-Resistant pESI-HarboringSalmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020–2023 [PDF - 2.38 MB - 11 pages]
J. Perry et al.

Salmonella enterica serovar Muenchen emerged in Israel in 2018 and became a major public health threat. We aimed to determine the role of poultry in rising human cases, transmission routes within the broiler industry, and genetic similarity toSalmonella Muenchen found globally. We used whole-genome sequencing to compareSalmonella Muenchen isolates from poultry, food, and humans collected in Israel (2020–2023; n = 109) and globally (n = 125).Salmonella Muenchen sequence type 82 isolates from Israel harbored pESI plasmid, exhibited high genetic similarity between human and poultry sources, and closely resembled international pESI-positive strains; we found quinolone-resistance determinants in 58.6% of isolates.Salmonella Muenchen prevalence in commercial broiler flocks was 61.5% (95% CI 51.5%–71.5%); strains could not be traced to breeder flocks, but on-farm persistence existed. The clonal spread ofSalmonella Muenchen in poultry contributes to increased incidence in humans. Horizontal transmission in broilers requires control measures to protect public health.

EIDPerry J, Rakler T, Arnold K, Wiseman A, Satuchne C, Pima Y, et al. Multidrug-Resistant pESI-Harboring Salmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020–2023. Emerg Infect Dis. 2025;31(10):1969-1979. https://doi.org/10.3201/eid3110.250191
AMAPerry J, Rakler T, Arnold K, et al. Multidrug-Resistant pESI-Harboring Salmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020–2023.Emerging Infectious Diseases. 2025;31(10):1969-1979. doi:10.3201/eid3110.250191.
APAPerry, J., Rakler, T., Arnold, K., Wiseman, A., Satuchne, C., Pima, Y....Elnekave, E. (2025). Multidrug-Resistant pESI-Harboring Salmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020–2023.Emerging Infectious Diseases,31(10), 1969-1979. https://doi.org/10.3201/eid3110.250191.
Dispatches

Bat-Associated Hemotropic Mycoplasmas in Immunosuppressed Children, Spain, 2024 [PDF - 582 KB - 4 pages]
F. Esperón et al.

We report the detection of hemotropic mycoplasmas in 4 immunosuppressed pediatric patients in Spain: 2 solid organ transplant recipients, 1 hematopoietic stem cell transplant recipient, and 1 cancer patient. Sequences were 100% identical to a strain previously identified inMiniopterus schreibersii bats, which raises concerns about unnoticed zoonotic transmission.

EIDEsperón F, Martín-Maldonado B, Iglesias I, Neves E, Seri E, García-Sanchez P, et al. Bat-Associated Hemotropic Mycoplasmas in Immunosuppressed Children, Spain, 2024. Emerg Infect Dis. 2025;31(10):1980-1983. https://doi.org/10.3201/eid3110.250862
AMAEsperón F, Martín-Maldonado B, Iglesias I, et al. Bat-Associated Hemotropic Mycoplasmas in Immunosuppressed Children, Spain, 2024.Emerging Infectious Diseases. 2025;31(10):1980-1983. doi:10.3201/eid3110.250862.
APAEsperón, F., Martín-Maldonado, B., Iglesias, I., Neves, E., Seri, E., García-Sanchez, P....Méndez-Echevarría, A. (2025). Bat-Associated Hemotropic Mycoplasmas in Immunosuppressed Children, Spain, 2024.Emerging Infectious Diseases,31(10), 1980-1983. https://doi.org/10.3201/eid3110.250862.

Detection of Monkeypox Virus Clade Ib DNA in Wastewater Solids at Wastewater Treatment Plants, United States [PDF - 736 KB - 4 pages]
A. B. Boehm et al.

We used a sensitive and specific PCR to detect monkeypox virus clade Ib DNA from >3,000 wastewater samples collected prospectively across the United States. Monkeypox virus clade Ib DNA was detected in 1 sample from a location with a confirmed case; it was not detected in locations with no confirmed cases.

EIDBoehm AB, Wolfe MK, Bidwell AL, White BJ, Shelden B, Duong D. Detection of Monkeypox Virus Clade Ib DNA in Wastewater Solids at Wastewater Treatment Plants, United States. Emerg Infect Dis. 2025;31(10):1984-1987. https://doi.org/10.3201/eid3110.250270
AMABoehm AB, Wolfe MK, Bidwell AL, et al. Detection of Monkeypox Virus Clade Ib DNA in Wastewater Solids at Wastewater Treatment Plants, United States.Emerging Infectious Diseases. 2025;31(10):1984-1987. doi:10.3201/eid3110.250270.
APABoehm, A. B., Wolfe, M. K., Bidwell, A. L., White, B. J., Shelden, B., & Duong, D. (2025). Detection of Monkeypox Virus Clade Ib DNA in Wastewater Solids at Wastewater Treatment Plants, United States.Emerging Infectious Diseases,31(10), 1984-1987. https://doi.org/10.3201/eid3110.250270.

Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024 [PDF - 858 KB - 4 pages]
F. Baalmann et al.

We report a case of severe acute kidney injury in a patient in Germany infected with Seoul virus. Clinical and laboratory analysis linked the infection to a pet rat breeding facility in central Germany. Increased surveillance and a One Health approach are needed, given the rising popularity of pet rats.

EIDBaalmann F, Hönemann M, Drewes S, Eiden M, Mehl C, Tappe D, et al. Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024. Emerg Infect Dis. 2025;31(10):1988-1991. https://doi.org/10.3201/eid3110.250362
AMABaalmann F, Hönemann M, Drewes S, et al. Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024.Emerging Infectious Diseases. 2025;31(10):1988-1991. doi:10.3201/eid3110.250362.
APABaalmann, F., Hönemann, M., Drewes, S., Eiden, M., Mehl, C., Tappe, D....Münch, J. (2025). Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024.Emerging Infectious Diseases,31(10), 1988-1991. https://doi.org/10.3201/eid3110.250362.

Antimicrobial-Resistant Clonal Complex 11Neisseria meningitidis–Associated Urethritis Cluster, Thailand [PDF - 1.13 MB - 6 pages]
J. C. Cartee et al.

Sexually transmitted infections clinics in Bangkok, Thailand, reported increasing numbers of men withNeisseria meningitidis–associated urethritis during 2017–2023. Genomic analysis indicated global expansion of the nongroupable clonal complex 11N. meningitidis urethritis clade. Continued global surveillance is needed to monitor the spread of antimicrobial-resistantN. meningitidis with urethral adaptability.

EIDCartee JC, Cherdtrakulkiat T, Joseph SJ, Kittiyaowamarn R, Girdthep N, Sangprasert P, et al. Antimicrobial-Resistant Clonal Complex 11 Neisseria meningitidis–Associated Urethritis Cluster, Thailand. Emerg Infect Dis. 2025;31(10):1992-1997. https://doi.org/10.3201/eid3110.250464
AMACartee JC, Cherdtrakulkiat T, Joseph SJ, et al. Antimicrobial-Resistant Clonal Complex 11 Neisseria meningitidis–Associated Urethritis Cluster, Thailand.Emerging Infectious Diseases. 2025;31(10):1992-1997. doi:10.3201/eid3110.250464.
APACartee, J. C., Cherdtrakulkiat, T., Joseph, S. J., Kittiyaowamarn, R., Girdthep, N., Sangprasert, P....Tribuddharat, C. (2025). Antimicrobial-Resistant Clonal Complex 11 Neisseria meningitidis–Associated Urethritis Cluster, Thailand.Emerging Infectious Diseases,31(10), 1992-1997. https://doi.org/10.3201/eid3110.250464.

Emergence and Polyclonal Dissemination ofblaNDM-7–Carrying InX3 Plasmid inEnterobacter cloacae Complex, France, 2021–2023 [PDF - 1.15 MB - 5 pages]
I. Rezzoug et al.

Among 3,367 New Delhi metallo-β-lactamase–producing Enterobacterales isolates collected in France during 2021–2023, we found theblaNDM-7 gene systematically localized on 2 closely related InX3 plasmids known to harbor antimicrobial resistance and virulence factors. Enhanced surveillance to monitor spread of antimicrobial resistance is needed among New Delhi metallo-β-lactamase–producing Enterobacterales.

EIDRezzoug I, Girlich D, Birer A, Bonnet R, Poiraud J, Bogaerts P, et al. Emergence and Polyclonal Dissemination of blaNDM-7–Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021–2023. Emerg Infect Dis. 2025;31(10):1998-2002. https://doi.org/10.3201/eid3110.250830
AMARezzoug I, Girlich D, Birer A, et al. Emergence and Polyclonal Dissemination of blaNDM-7–Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021–2023.Emerging Infectious Diseases. 2025;31(10):1998-2002. doi:10.3201/eid3110.250830.
APARezzoug, I., Girlich, D., Birer, A., Bonnet, R., Poiraud, J., Bogaerts, P....Dortet, L. (2025). Emergence and Polyclonal Dissemination of blaNDM-7–Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021–2023.Emerging Infectious Diseases,31(10), 1998-2002. https://doi.org/10.3201/eid3110.250830.

Genomic Investigation of Disseminated Gonococcal Infections, Minnesota, USA, 2024 [PDF - 1.04 MB - 5 pages]
D. Evans et al.

This article summarizes a genomic investigation of a 4-fold increase in disseminated gonococcal infections in Minnesota, USA, in 2024. We detected the emergence of aNeisseria gonorrhoeae strain of a rarely observed sequence type, which carries aporB1a allele previously associated with disseminated disease and lacks a gonococcal genetic island.

EIDEvans D, Friedlander H, Bo-Subait K, Dennis J, Kaiyalethe J, Craft B, et al. Genomic Investigation of Disseminated Gonococcal Infections, Minnesota, USA, 2024. Emerg Infect Dis. 2025;31(10):2003-2007. https://doi.org/10.3201/eid3110.250785
AMAEvans D, Friedlander H, Bo-Subait K, et al. Genomic Investigation of Disseminated Gonococcal Infections, Minnesota, USA, 2024.Emerging Infectious Diseases. 2025;31(10):2003-2007. doi:10.3201/eid3110.250785.
APAEvans, D., Friedlander, H., Bo-Subait, K., Dennis, J., Kaiyalethe, J., Craft, B....Lynfield, R. (2025). Genomic Investigation of Disseminated Gonococcal Infections, Minnesota, USA, 2024.Emerging Infectious Diseases,31(10), 2003-2007. https://doi.org/10.3201/eid3110.250785.

Fatal Pneumocephalus Caused by HypervirulentKlebsiella pneumoniae, Germany [PDF - 2.26 MB - 5 pages]
N. Gläser et al.

We report a fatal case of pneumocephalus in Germany caused by hypervirulentKlebsiellapneumoniae sequence type 23, confirmed by using clinical, histopathologic, and genomic analyses. The patient reported no travel history, suggesting local emergence. This unusual case reveals an unclear pathogen prevalence and demonstrates the need for increased awareness of global spread.

EIDGläser N, Schwab N, Pfeifer Y, Wahl A, Fischer MA, Osterloh A, et al. Fatal Pneumocephalus Caused by Hypervirulent Klebsiella pneumoniae, Germany. Emerg Infect Dis. 2025;31(10):2008-2012. https://doi.org/10.3201/eid3110.250877
AMAGläser N, Schwab N, Pfeifer Y, et al. Fatal Pneumocephalus Caused by Hypervirulent Klebsiella pneumoniae, Germany.Emerging Infectious Diseases. 2025;31(10):2008-2012. doi:10.3201/eid3110.250877.
APAGläser, N., Schwab, N., Pfeifer, Y., Wahl, A., Fischer, M. A., Osterloh, A....Hagemann, J. (2025). Fatal Pneumocephalus Caused by Hypervirulent Klebsiella pneumoniae, Germany.Emerging Infectious Diseases,31(10), 2008-2012. https://doi.org/10.3201/eid3110.250877.

ZoonoticBaylisascaris procyonis Infection in Raccoons, Mississippi, USA, 2023–2024 [PDF - 916 KB - 4 pages]
B. L. Huerta-Beltrán et al.

Baylisascaris procyonis, an emerging zoonotic parasite, causes clinically significant visceral, ophthalmologic, and neurologic disease in humans. We screened raccoons (n = 46) collected from central and southern Mississippi forB. procyonis by necropsy (13.0% prevalence) and droplet digital PCR of feces (26.7% prevalence). Further surveillance to determine raccoon infection rates throughout Mississippi is indicated.

EIDHuerta-Beltrán BL, Zhao H, Mills S, Berry J, Janous W, Ervin J, et al. Zoonotic Baylisascaris procyonis Infection in Raccoons, Mississippi, USA, 2023–2024. Emerg Infect Dis. 2025;31(10):2013-2016. https://doi.org/10.3201/eid3110.250658
AMAHuerta-Beltrán BL, Zhao H, Mills S, et al. Zoonotic Baylisascaris procyonis Infection in Raccoons, Mississippi, USA, 2023–2024.Emerging Infectious Diseases. 2025;31(10):2013-2016. doi:10.3201/eid3110.250658.
APAHuerta-Beltrán, B. L., Zhao, H., Mills, S., Berry, J., Janous, W., Ervin, J....Hearst, S. M. (2025). Zoonotic Baylisascaris procyonis Infection in Raccoons, Mississippi, USA, 2023–2024.Emerging Infectious Diseases,31(10), 2013-2016. https://doi.org/10.3201/eid3110.250658.

Genetic Cluster of Extended-Spectrum β-lactamase–ProducingKlebsiella pneumoniae in Humans and Food, Switzerland, 2018–2019 [PDF - 2.22 MB - 5 pages]
L. Aguilar-Bultet et al.

We describe a cluster of genetically related extended-spectrum β-lactamase–producingKlebsiella pneumoniae sequence type 14 recovered from human clinical samples and an alfalfa-cress sample collected by systematic food sampling in Basel, Switzerland. Our findings suggest food could represent a reservoir contributing to spread of extended-spectrum β-lactamase–producing Enterobacterales.

EIDAguilar-Bultet L, Gómez-Sanz E, Vock I, Alt M, Schindler R, Pekerman L, et al. Genetic Cluster of Extended-Spectrum β-lactamase–Producing Klebsiella pneumoniae in Humans and Food, Switzerland, 2018–2019. Emerg Infect Dis. 2025;31(10):2017-2021. https://doi.org/10.3201/eid3110.250253
AMAAguilar-Bultet L, Gómez-Sanz E, Vock I, et al. Genetic Cluster of Extended-Spectrum β-lactamase–Producing Klebsiella pneumoniae in Humans and Food, Switzerland, 2018–2019.Emerging Infectious Diseases. 2025;31(10):2017-2021. doi:10.3201/eid3110.250253.
APAAguilar-Bultet, L., Gómez-Sanz, E., Vock, I., Alt, M., Schindler, R., Pekerman, L....Tschudin-Sutter, S. (2025). Genetic Cluster of Extended-Spectrum β-lactamase–Producing Klebsiella pneumoniae in Humans and Food, Switzerland, 2018–2019.Emerging Infectious Diseases,31(10), 2017-2021. https://doi.org/10.3201/eid3110.250253.

Emergence ofBordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023 [PDF - 616 KB - 3 pages]
N. Shekhar et al.

We investigatedBordetella holmesii andBordetella pertussis in 935 suspected pertussis cases in northern India (2019–2023) using PCR and serology.B. holmesii showed increased prevalence in pertussis cases, particularly in older children, highlighting its emerging role and the need for ongoing surveillance and adjusted prevention strategies.

EIDShekhar N, Sharma D, Chakraborty S, Kumar R, Rawat R, Kaundal N, et al. Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023. Emerg Infect Dis. 2025;31(10):2022-2024. https://doi.org/10.3201/eid3110.241659
AMAShekhar N, Sharma D, Chakraborty S, et al. Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023.Emerging Infectious Diseases. 2025;31(10):2022-2024. doi:10.3201/eid3110.241659.
APAShekhar, N., Sharma, D., Chakraborty, S., Kumar, R., Rawat, R., Kaundal, N....Gautam, V. (2025). Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023.Emerging Infectious Diseases,31(10), 2022-2024. https://doi.org/10.3201/eid3110.241659.

Escherichia coli Sequence Type 131-H22 in Parrots from Illegal Pet Trade, Brazil, 2024 [PDF - 1.27 MB - 4 pages]
V. Rocha et al.

Escherichia coli sequence type 131:H:22 is a consequential lineage of extraintestinal pathogenicE. coli, associated with human pyelonephritis and sepsis. We report the transmission of avian pathogenicE. coli in a parrot rehabilitation center in Brazil and the presence of a high-risk zoonotic lineage of extraintestinal pathogenicE. coli sequence type 131-H22.

EIDRocha V, Barbosa F, Ruiz J, Christensen H, Knöbl T. Escherichia coli Sequence Type 131-H22 in Parrots from Illegal Pet Trade, Brazil, 2024. Emerg Infect Dis. 2025;31(10):2025-2028. https://doi.org/10.3201/eid3110.241279
AMARocha V, Barbosa F, Ruiz J, et al. Escherichia coli Sequence Type 131-H22 in Parrots from Illegal Pet Trade, Brazil, 2024.Emerging Infectious Diseases. 2025;31(10):2025-2028. doi:10.3201/eid3110.241279.
APARocha, V., Barbosa, F., Ruiz, J., Christensen, H., & Knöbl, T. (2025). Escherichia coli Sequence Type 131-H22 in Parrots from Illegal Pet Trade, Brazil, 2024.Emerging Infectious Diseases,31(10), 2025-2028. https://doi.org/10.3201/eid3110.241279.

Zoonotic Soil-Transmitted Helminth Infections among Humans, Gabon [PDF - 2.35 MB - 5 pages]
H. Zhao et al.

We report human infections withNecator gorillae andStrongyloides fuelleborni, zoonotic helminths from nonhuman primates, in Gabon. We also detected a crypticAncylostoma species helminth. Infections occurred in settings of localized deforestation and environmental degradation, which increase human–animal contact. Surveillance to clarify the extent of human infections is needed.

EIDZhao H, Mutombo P, Mintsa-Nguema R, Nkoghe D, Atsame J, Watts M, et al. Zoonotic Soil-Transmitted Helminth Infections among Humans, Gabon. Emerg Infect Dis. 2025;31(10):2029-2033. https://doi.org/10.3201/eid3110.250816
AMAZhao H, Mutombo P, Mintsa-Nguema R, et al. Zoonotic Soil-Transmitted Helminth Infections among Humans, Gabon.Emerging Infectious Diseases. 2025;31(10):2029-2033. doi:10.3201/eid3110.250816.
APAZhao, H., Mutombo, P., Mintsa-Nguema, R., Nkoghe, D., Atsame, J., Watts, M....Bradbury, R. S. (2025). Zoonotic Soil-Transmitted Helminth Infections among Humans, Gabon.Emerging Infectious Diseases,31(10), 2029-2033. https://doi.org/10.3201/eid3110.250816.

Investigation of Possible Intraoperative Transmission ofBrucella melitensis, Slovenia [PDF - 700 KB - 4 pages]
I. Potparić et al.

We report possible intraoperative transmission ofBrucella melitensis in Slovenia, likely caused by aerosolized particles during wound irrigation. Whole-genome multilocus sequence typing revealed that isolates from the patient and the surgeon belonged to the same transmission cluster, differing by 1 allele. Our findings raise awareness of occupational risks faced by orthopedic surgeons.

EIDPotparić I, Bošnjak K, Avberšek J, Papić B, Bogovič P, Vodičar P, et al. Investigation of Possible Intraoperative Transmission of Brucella melitensis, Slovenia. Emerg Infect Dis. 2025;31(10):2034-2037. https://doi.org/10.3201/eid3110.250587
AMAPotparić I, Bošnjak K, Avberšek J, et al. Investigation of Possible Intraoperative Transmission of Brucella melitensis, Slovenia.Emerging Infectious Diseases. 2025;31(10):2034-2037. doi:10.3201/eid3110.250587.
APAPotparić, I., Bošnjak, K., Avberšek, J., Papić, B., Bogovič, P., Vodičar, P....Vodičar, M. (2025). Investigation of Possible Intraoperative Transmission of Brucella melitensis, Slovenia.Emerging Infectious Diseases,31(10), 2034-2037. https://doi.org/10.3201/eid3110.250587.
Research Letters

Cutaneous Coccidioidomycosis Mimicking Rosacea in Immunosuppressed Patient, Arizona, USA, 2024 [PDF - 1.13 MB - 3 pages]
S. Obagi et al.

An immunocompromised patient in Arizona, USA, experienced cutaneous coccidioidomycosis mimicking rosacea-like dermatitis; she was receiving vandetanib therapy. Histopathology confirmed the diagnosis despite inconclusive serologic results. Lesions resolved with fluconazole treatment, but blue-gray hyperpigmentation persisted, likely linked to vandetanib. This case highlights diagnostic challenges in endemic fungal infections and rare drug-associated hyperpigmentation.

EIDObagi S, Murphy LE, Hendricks AJ, Hiatt K, Miraflor A, Cashman RE, et al. Cutaneous Coccidioidomycosis Mimicking Rosacea in Immunosuppressed Patient, Arizona, USA, 2024. Emerg Infect Dis. 2025;31(10):2038-2040. https://doi.org/10.3201/eid3110.250010
AMAObagi S, Murphy LE, Hendricks AJ, et al. Cutaneous Coccidioidomycosis Mimicking Rosacea in Immunosuppressed Patient, Arizona, USA, 2024.Emerging Infectious Diseases. 2025;31(10):2038-2040. doi:10.3201/eid3110.250010.
APAObagi, S., Murphy, L. E., Hendricks, A. J., Hiatt, K., Miraflor, A., Cashman, R. E....Fazel, M. (2025). Cutaneous Coccidioidomycosis Mimicking Rosacea in Immunosuppressed Patient, Arizona, USA, 2024.Emerging Infectious Diseases,31(10), 2038-2040. https://doi.org/10.3201/eid3110.250010.

Jorge Lobo’s Disease in Child with Tick Exposure, Brazil [PDF - 1.68 MB - 4 pages]
F. Gonçalves et al.

Jorge Lobo’s disease (JLD), caused byParacoccidioides lobogeorgii, primarily affects inhabitants of the Amazon Forest. We report a 9-year-old boy in Brazil who had JLD diagnosed after a tick bite. The rarity of pediatric cases likely reflects surveillance gaps. Increased clinical awareness is crucial for early JLD detection and intervention, especially in endemic regions.

EIDGonçalves F, Laporta G, Neves S, de Barros V, Bispo R, Sbardelott Y, et al. Jorge Lobo’s Disease in Child with Tick Exposure, Brazil. Emerg Infect Dis. 2025;31(10):2040-2043. https://doi.org/10.3201/eid3110.250209
AMAGonçalves F, Laporta G, Neves S, et al. Jorge Lobo’s Disease in Child with Tick Exposure, Brazil.Emerging Infectious Diseases. 2025;31(10):2040-2043. doi:10.3201/eid3110.250209.
APAGonçalves, F., Laporta, G., Neves, S., de Barros, V., Bispo, R., Sbardelott, Y....de Melo Teixeira, M. (2025). Jorge Lobo’s Disease in Child with Tick Exposure, Brazil.Emerging Infectious Diseases,31(10), 2040-2043. https://doi.org/10.3201/eid3110.250209.

Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-ResistantNeisseria gonorrhoeae [PDF - 475 KB - 3 pages]
H. Mizushima et al.

Prophylaxis for ophthalmia neonatorum remains in use despite decreased incidence of the condition. We report a breakthrough case of neonatal conjunctivitis in Japan caused by a levofloxacin-resistantNeisseria gonorrhoeae bacteria strain, co-infected withChlamydia trachomatis bacteria. This case highlights failures in screening, prophylaxis, and treatment, underscoring the need to reassess prevention strategies.

EIDMizushima H, Komori M, Yoshida C, Miyairi I. Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae. Emerg Infect Dis. 2025;31(10):2043-2045. https://doi.org/10.3201/eid3110.250895
AMAMizushima H, Komori M, Yoshida C, et al. Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae.Emerging Infectious Diseases. 2025;31(10):2043-2045. doi:10.3201/eid3110.250895.
APAMizushima, H., Komori, M., Yoshida, C., & Miyairi, I. (2025). Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae.Emerging Infectious Diseases,31(10), 2043-2045. https://doi.org/10.3201/eid3110.250895.

Disseminated Blastomycosis Mimicking Tuberculosis, China [PDF - 1.39 MB - 3 pages]
C. Guo et al.

Blastomycosis is endemic in central and southern North America but rare in China. It can mimic community-acquired pneumonia, tuberculosis, or cancer. We describe a patient who initially had tuberculosis diagnosed and later had blastomycosis diagnosed through metagenomic detection, which aided diagnosis and treatment. Clinicians should consider blastomycosis in differential diagnoses for respiratory diseases.

EIDGuo C, Pan Y, Yu J, Yao L, He Y, Cui J, et al. Disseminated Blastomycosis Mimicking Tuberculosis, China. Emerg Infect Dis. 2025;31(10):2046-2048. https://doi.org/10.3201/eid3110.250671
AMAGuo C, Pan Y, Yu J, et al. Disseminated Blastomycosis Mimicking Tuberculosis, China.Emerging Infectious Diseases. 2025;31(10):2046-2048. doi:10.3201/eid3110.250671.
APAGuo, C., Pan, Y., Yu, J., Yao, L., He, Y., Cui, J....Pang, Y. (2025). Disseminated Blastomycosis Mimicking Tuberculosis, China.Emerging Infectious Diseases,31(10), 2046-2048. https://doi.org/10.3201/eid3110.250671.

Crimean-Congo Hemorrhagic Fever Virus Circulation in Wild European Rabbits, Portugal, 2018−2023 [PDF - 850 KB - 4 pages]
C. Baptista et al.

Crimean-Congo hemorrhagic fever virus is considered a public health risk in southwestern Europe. We surveyed serum samples from 667 European rabbits across Portugal, a rabbit species known to host immatureHyalomma lusitanicum ticks. We found low levels of virus antibodies (>1%), with a localized cluster reaching 5.77% in southern populations.

EIDBaptista C, Santos N, Vial L, Jori F. Crimean-Congo Hemorrhagic Fever Virus Circulation in Wild European Rabbits, Portugal, 2018−2023. Emerg Infect Dis. 2025;31(10):2048-2051. https://doi.org/10.3201/eid3110.250184
AMABaptista C, Santos N, Vial L, et al. Crimean-Congo Hemorrhagic Fever Virus Circulation in Wild European Rabbits, Portugal, 2018−2023.Emerging Infectious Diseases. 2025;31(10):2048-2051. doi:10.3201/eid3110.250184.
APABaptista, C., Santos, N., Vial, L., & Jori, F. (2025). Crimean-Congo Hemorrhagic Fever Virus Circulation in Wild European Rabbits, Portugal, 2018−2023.Emerging Infectious Diseases,31(10), 2048-2051. https://doi.org/10.3201/eid3110.250184.

Increased Rates ofPurpureocillium lilacinum Mold among Laboratory Culture Results, United States [PDF - 493 KB - 4 pages]
D. J. Smith et al.

Purpureocillium lilacinum, a common environmental mold and bionematicide, can cause human infections. At a major US commercial laboratory during March 2019–February 2025,P. lilacinum culture rates increased; rates were highest in the South Atlantic and Pacific states. Nonculture-based diagnostic tools such as microscopy may help identify and confirm clinical infection earlier.

EIDSmith DJ, López LF, Lyman M, Paisley-Jones C, Benedict K. Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United States. Emerg Infect Dis. 2025;31(10):2051-2054. https://doi.org/10.3201/eid3110.250715
AMASmith DJ, López LF, Lyman M, et al. Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United States.Emerging Infectious Diseases. 2025;31(10):2051-2054. doi:10.3201/eid3110.250715.
APASmith, D. J., López, L. F., Lyman, M., Paisley-Jones, C., & Benedict, K. (2025). Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United States.Emerging Infectious Diseases,31(10), 2051-2054. https://doi.org/10.3201/eid3110.250715.

Angiostrongylus cantonensis Lungworms in Definitive and Intermediate Hosts, Madagascar, 2024 [PDF - 1.00 MB - 3 pages]
L. A. Maminirina et al.

We assessed the prevalence of the rat lungworm,Angiostrongylus cantonensis, in rats and snails in Toamasina, Madagascar, using molecular techniques. Although no human cases of neuroangiostrongyliasis have been reported in Madagascar, the pathogen’s presence in definitive hosts (2.5%, 2/78) and intermediate hosts (26.9%, 35/130) reveals active circulation and potential zoonotic risk.

EIDMaminirina LA, Bodoarison ZI, Rajerison M, Ferdinand S, Ramasindrazana B. Angiostrongylus cantonensis Lungworms in Definitive and Intermediate Hosts, Madagascar, 2024. Emerg Infect Dis. 2025;31(10):2054-2056. https://doi.org/10.3201/eid3110.241741
AMAMaminirina LA, Bodoarison ZI, Rajerison M, et al. Angiostrongylus cantonensis Lungworms in Definitive and Intermediate Hosts, Madagascar, 2024.Emerging Infectious Diseases. 2025;31(10):2054-2056. doi:10.3201/eid3110.241741.
APAMaminirina, L. A., Bodoarison, Z. I., Rajerison, M., Ferdinand, S., & Ramasindrazana, B. (2025). Angiostrongylus cantonensis Lungworms in Definitive and Intermediate Hosts, Madagascar, 2024.Emerging Infectious Diseases,31(10), 2054-2056. https://doi.org/10.3201/eid3110.241741.

Detection ofBurkholderia thailandensis in Soil Samples, Suriname [PDF - 442 KB - 3 pages]
J. Savelkoel et al.

Melioidosis, caused by the highly lethal pathogenBurkholderia pseudomallei, is emerging in North and South America. We studied soil samples in Suriname to determine endemicity ofBurkholderia species.B. thailandensis was isolated, butB. pseudomallei was not. A multidisciplinary approach could establish clinical and ecologic distribution of bothBurholderia species in Suriname.

EIDSavelkoel J, Zimmermann R, Tjon A, Dzebisasjvili T, Lanzl M, Matamoros S, et al. Detection of Burkholderia thailandensis in Soil Samples, Suriname. Emerg Infect Dis. 2025;31(10):2057-2059. https://doi.org/10.3201/eid3110.251114
AMASavelkoel J, Zimmermann R, Tjon A, et al. Detection of Burkholderia thailandensis in Soil Samples, Suriname.Emerging Infectious Diseases. 2025;31(10):2057-2059. doi:10.3201/eid3110.251114.
APASavelkoel, J., Zimmermann, R., Tjon, A., Dzebisasjvili, T., Lanzl, M., Matamoros, S....Wiersinga, W. (2025). Detection of Burkholderia thailandensis in Soil Samples, Suriname.Emerging Infectious Diseases,31(10), 2057-2059. https://doi.org/10.3201/eid3110.251114.

Detection of Immunity Gap before Measles Outbreak, Ho Chi Minh City, Vietnam, 2024 [PDF - 957 KB - 4 pages]
T. Ong et al.

In 2022, we established a residual sample serosurveillance program in Ho Chi Minh City, Vietnam. During September 2022–April 2024, we found low measles antibody seroprevalence in children in the city’s western region, where a measles outbreak began in May 2024. Serosurveillance could be a useful tool for outbreak prediction and prevention.

EIDOng T, Thuy C, Tam N, Nga L, Uyen NV, Lan T, et al. Detection of Immunity Gap before Measles Outbreak, Ho Chi Minh City, Vietnam, 2024. Emerg Infect Dis. 2025;31(10):2059-2062. https://doi.org/10.3201/eid3110.250234
AMAOng T, Thuy C, Tam N, et al. Detection of Immunity Gap before Measles Outbreak, Ho Chi Minh City, Vietnam, 2024.Emerging Infectious Diseases. 2025;31(10):2059-2062. doi:10.3201/eid3110.250234.
APAOng, T., Thuy, C., Tam, N., Nga, L., Uyen, N. V., Lan, T....Van Tan, L. (2025). Detection of Immunity Gap before Measles Outbreak, Ho Chi Minh City, Vietnam, 2024.Emerging Infectious Diseases,31(10), 2059-2062. https://doi.org/10.3201/eid3110.250234.
EIN Letter

Emerging Sexual Transmission ofTrichophyton mentagrophytes Genotype VII Infections, United States [PDF - 596 KB - 3 pages]
P. Anand et al.

Trichophyton mentagrophytes genotype VII (TMVII) is an emerging dermatophyte strain associated with sexual transmission among men who have sex with men. A hypothesis-generating query of US infectious diseases specialists found that 56% had heard of TMVII and 23% knew how to treat TMVII infections, underscoring a need for increased clinician education.

EIDAnand P, Quilter L, Penney J, Polgreen PM, Beekmann SE, Gold J. Emerging Sexual Transmission of Trichophyton mentagrophytes Genotype VII Infections, United States. Emerg Infect Dis. 2025;31(10):2064-2066. https://doi.org/10.3201/eid3110.251056
AMAAnand P, Quilter L, Penney J, et al. Emerging Sexual Transmission of Trichophyton mentagrophytes Genotype VII Infections, United States.Emerging Infectious Diseases. 2025;31(10):2064-2066. doi:10.3201/eid3110.251056.
APAAnand, P., Quilter, L., Penney, J., Polgreen, P. M., Beekmann, S. E., & Gold, J. (2025). Emerging Sexual Transmission of Trichophyton mentagrophytes Genotype VII Infections, United States.Emerging Infectious Diseases,31(10), 2064-2066. https://doi.org/10.3201/eid3110.251056.
Letters

Invasive UrogenitalNeisseria meningitidis Serogroup Y Multilocus Sequence Type 1466 [PDF - 231 KB - 1 page]
C. George et al.
EIDGeorge C, Varadhan H, Naqvi S, Locker B, Howes M, van Hal S, et al. Invasive Urogenital Neisseria meningitidis Serogroup Y Multilocus Sequence Type 1466. Emerg Infect Dis. 2025;31(10):2067. https://doi.org/10.3201/eid3110.250902
AMAGeorge C, Varadhan H, Naqvi S, et al. Invasive Urogenital Neisseria meningitidis Serogroup Y Multilocus Sequence Type 1466.Emerging Infectious Diseases. 2025;31(10):2067. doi:10.3201/eid3110.250902.
APAGeorge, C., Varadhan, H., Naqvi, S., Locker, B., Howes, M., van Hal, S....Lahra, M. M. (2025). Invasive Urogenital Neisseria meningitidis Serogroup Y Multilocus Sequence Type 1466.Emerging Infectious Diseases,31(10), 2067. https://doi.org/10.3201/eid3110.250902.
Etymologia

Malassezia [mal″ə-sē′zhə] [PDF - 952 KB - 1 page]
F. P. Sellera et al.
EIDSellera FP, Ollhoff RD, Pogliani FC. Malassezia [mal″ə-sē′zhə]. Emerg Infect Dis. 2025;31(10):2063. https://doi.org/10.3201/eid3110.221743
AMASellera FP, Ollhoff RD, Pogliani FC. Malassezia [mal″ə-sē′zhə].Emerging Infectious Diseases. 2025;31(10):2063. doi:10.3201/eid3110.221743.
APASellera, F. P., Ollhoff, R. D., & Pogliani, F. C. (2025). Malassezia [mal″ə-sē′zhə].Emerging Infectious Diseases,31(10), 2063. https://doi.org/10.3201/eid3110.221743.
About the Cover

A Personal Journey Through the Microbial World in Quilting [PDF - 1.62 MB - 2 pages]
L. Mitchell
EIDMitchell L. A Personal Journey Through the Microbial World in Quilting. Emerg Infect Dis. 2025;31(10):2068-2069. https://doi.org/10.3201/eid3110.ac3110
AMAMitchell L. A Personal Journey Through the Microbial World in Quilting.Emerging Infectious Diseases. 2025;31(10):2068-2069. doi:10.3201/eid3110.ac3110.
APAMitchell, L. (2025). A Personal Journey Through the Microbial World in Quilting.Emerging Infectious Diseases,31(10), 2068-2069. https://doi.org/10.3201/eid3110.ac3110.

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Supplement—October 2025

Supplement
  • Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022–September 2023
    A. M. Leis et al.
  • Nonspecific Symptoms Attributable to Lyme Disease in High-Incidence Areas, United States, 2017–2021
    C. C. Nawrocki et al.

    For some patients who have Lyme disease (LD), nonspecific symptoms can persist after treatment and impair quality of life. Estimating the frequency and duration of such symptoms is challenging. Using commercial insurance claims data from 2017–2021 for enrollees residing in states where LD is common, we identified 24,503 case-patients with LD and matched them (1:5) with 122,095 control-patients with other diagnoses by demographics, medical service date, and inpatient/outpatient setting. We compared relative frequencies of diagnosis codes for pain, fatigue, and cognitive difficulties between case-patients and control-patients in the year after diagnosis. Those symptom codes occurred 5.0% more frequently among case-patients than among control-patients and comprised »11.0% of the total symptom codes among case-patients. Symptom code frequency among case-patients declined significantly in the 6–12 months after LD diagnosis and reached levels similar to control-patients by the end of the year, with the exception of fatigue.

  • Progress Toward Understanding Infection-Associated Chronic Conditions and Illnesses
    A. E. Fiore
  • Persistence of Symptoms among Commercially Insured Patients with Coccidioidomycosis, United States, 2017–2023
    I. Hennessee et al.

    Some patients with coccidioidomycosis experience prolonged respiratory and systemic symptoms. However, data on prevalence and persistence of most symptoms are lacking. Using an insurance claims database, we identified patients with coccidioidomycosis diagnoses in the United States during 2017–2023. We assessed prevalence of associated symptoms from 6 months before to 1 year after first diagnosis code (index date) and compared post–index date prevalence to baseline (within 6 to 4 months before index date). Among 2,640 patients, cough (20.8%), dyspnea (13.0%), and fatigue (8.8%) were the most common symptoms at index date. Dyspnea and erythema nodosum were elevated 3–6 months post–index date (p<0.03), and fatigue, headache, joint pain, and weakness were elevated 9–12 months post–index date compared with baseline (p<0.05).These findings demonstrate that symptoms can persist in coccidioidomycosis patients, which could help inform clinical management and refine estimates of the health and economic burden of coccidioidomycosis.

Top

Volume 31, Number 11—November 2025

Synopses
  • Haematospirillum jordaniae Infections after Recreational Exposure to River Water, Pennsylvania, USA, 2020
    M. Dulcey et al.
  • Trichosporon austroamericanum Infections among Hospitalized Patients, France, 2022–2024
    E. Burel et al.

    During 2022–2024, six cases of invasive fungal infection occurred among immunocompromised patients at Marseille University Hospital, Marseille, France. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry initially identifiedTrichosporon inkin fungi. However, phylogenetic analysis of intergenic spacer region 1 and whole-genome sequences revealed the genetically distinct speciesT. austroamericanum. Analysis of core genome and mitogenome from 6 patient isolates and 1 environmental isolate revealed substantial genetic diversity amongT. austroamericanum strains, indicating a polyclonal outbreak. Furthermore, the mitochondrial genome emerged as a potential marker for intraspecies differentiation, which potentially could aid in epidemiologic investigations. Identified in 2024 but potentially underestimated,T. austroamericanum has since been reported in case clusters from hospital settings in France, highlighting the need for accurate fungal identification and suggesting previously identifiedT. inkin cases should be re-evaluated forT. austroamericanum. ClinicalT. austroamericanum is emerging in hospital settings and should be included in the differential diagnosis of fungal infections.

Research
  • Two Independent Acquisitions of Multidrug Resistance GenelsaC inStreptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257
    B. Beall et al.

    Among >25,000 invasive pneumococcal disease isolates recovered in US locations during 2015–early 2024 through population-based surveillance, we detected 17 case isolates carrying thelsaC gene, which has been shown to confer resistance to clindamycin in group BStreptococcus. Sixteen isolates carried themef,msrD,tetM, andlsaC genes on a 29-kb mobile element acquired through an interspecies recombination event and were intermediately clindamycin resistant. One isolate acquired a 62-kb mobile element containing theermB,tetM, andlsaC genes through a transposition event. All 17 cases were in adults, including 4 adults experiencing homelessness and 9 with substance abuse problems. All 17lsaC-positive isolates shared a 5.2-kblsaC-containing element precisely integrated within the conservedoriT site of their respective mobile element. Those 17lsaC-positive strains were all serotype 20, multilocus sequence type 1257, and were recovered recently (2021–2024); isolates 1–16 represented emergent disease clusters in New York and Connecticut.

  • Community-Driven, Text Message–Based COVID-19 Surveillance System, Los Angeles County, California, USA, 2020–2024
    J. B. Braunfeld et al.

    Respiratory virus indicators were unreliable at the onset of the COVID-19 pandemic when testing availability was limited and residents with mild symptoms were advised to avoid unnecessary medical care. The Los Angeles County Department of Public Health (Los Angeles, California, USA) developed Angelenos in Action (AiA), a text message–based community syndromic surveillance system to monitor respiratory illness trends. Approximately 17,000 unique participants responded>1 time; 43% of participants continue to regularly respond to the survey. We assessed AiA’s performance by measuring correlation coefficients with reported COVID-19 case counts (0.975), sentinel laboratory SARS-CoV-2 test positivity rate (0.762), and wastewater SARS-CoV-2 concentrations (0.861). AiA performed strongly against 3 comparator surveillance methods and correlated particularly well with raw case counts. A moderate correlation was also noted between influenza test positivity rate and AiA data, indicating the system has potential to detect respiratory illness besides COVID-19.

  • Isolation and Characterization ofRickettsia finnyi, Novel Pathogenic Spotted Fever GroupRickettsia in Dogs, United States
    P. K. Korla et al.

    In 2020, a novel spotted fever groupRickettsia was described in 3 clinically ill dogs in the United States. Using naturally infected canine blood, the novelRickettsia sp. was isolated in epithelial (Vero E6) and mononuclear (DH82 and 030D) cell lines. The sequenced whole genome revealed a 1.27 Mb circular chromosome with 96.87% identity toRickettsia raoultii on the basis of average nucleotide identity analysis. A maximum-likelihood phylogeny tree placed the novelRickettsia in its own branch within the spotted fever group. Immunofluorescence revealed single rods localized along the membrane in epithelial cells and randomly distributed in the cytoplasm of mononuclear cells. We propose the nameRickettsia finnyi sp. nov., strain 2024-CO-Wats, which is available from national and international Rickettsial isolate reference collections. Fever and thrombocytopenia were among abnormalities in the 17 naturally infected dogs we describe, underscoring the pathogenic importance ofR. finnyi sp. nov. and its potential public health relevance.

  • TickborneNeoehrlichia mikurensis in the Blood of Blood Donors, Norway, 2023
    H. Quarsten et al.

    The tickborne bacterial pathogenNeoehrlichia mikurensis has been detected in <1% of blood donors in Sweden.N. mikurensis can give rise to asymptomatic persistent infections. Up to 25% ofIxodes ricinus ticks in southern Norway are infected withN. mikurensis. We investigated the incidence ofN. mikurensis infection among blood donors in this region. We detectedN. mikurensis in the blood of 45/499 (9%) blood donors by independent PCR methods; 69% of those were repeatedly positive 1–7 months after the first detection and tested negative after doxycycline treatment. We tested 8/19 adult recipients of potentially infected blood; none tested positive forN. mikurensis at the time of testing (191–301 days after transfusion). Our study identified a very high rate of infection withN. mikurensis in blood donors in Norway; whether infection can be transmitted by transfusion of blood products, however, remains unclear.

  • Monkeypox Virus Partial Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks
    J. Deng et al.
Dispatches
  • Borrelia afzelii Hepatitis in Patient Treated with Venetoclax and Obinutuzumab, Switzerland
    G. Capoferri et al.
  • Neoehrlichia mikurensis in Ticks and Tick-Bitten Persons, Sweden and Finland, 2008–2009
    E. Hero et al.

    By using PCR testing, we foundNeoehrlichia mikurensis DNA in 1.1% of ticks removed from persons in Sweden and Finland. Symptoms developed in 2 immunocompetent persons. Despite low transmission risk, infection can occur after short tick attachment. Our findings highlight the need to considerN. mikurensis in patients with unexplained symptoms after tick bite.

  • Two Autochthonous Cases of Anaplasmosis, Washington, USA, 2022–2023
    H. Schnitzler et al.

    We describe 2 cases of autochthonous human anaplasmosis in Washington, USA, where anaplasmosis has been rarely reported. Clinicians should consider anaplasmosis in the differential diagnosis for patients with compatible clinical symptoms after tick bite or time spent outdoors in an area whereIxodes pacificus ticks are present.

  • Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany
    R. Sprute et al.

    We report 3 cases of probable invasive pulmonary disease caused byBjerkandera spp. fungi in immunocompromised patients in Germany. Accurate identification required internal transcribed spacer sequencing. Response to antifungal treatment varied. Our report underlines the pathogenic potential ofBjerkandera spp. and the importance of molecular diagnostics in rare fungal infections.

  • Novel Dolphin Tupavirus from Stranded Atlantic White-Sided Dolphin with Severe Encephalitis, Canada, 2024
    O. Vernygora et al.

    We sequenced a novel rhabdovirus,Tupavirus delphini (dolphin tupavirus), from the brain of a stranded dead Atlantic white-sided dolphin with severe encephalitis in Canada. In situ hybridization linked presence of the virus to the animal’s brain pathology and death. Our findings underscore the importance of monitoring marine mammals for unexpected pathogens.

  • Shifting Dynamics of Dengue Virus Serotype 2 and Emergence of Cosmopolitan Genotype, Costa Rica, 2024
    M. González-Elizondo et al.

    Dengue remains a major public health challenge. In Costa Rica, we implemented nationwide genomic surveillance to track dengue virus serotype 2 cosmopolitan genotype emergence. Phylogenetic and eco-epidemiologic analyses revealed early detection, climate-driven spread, and spatial heterogeneity. Our findings underscore the need for integrated surveillance to guide adaptive responses to emerging arboviral threats.

  • Spiroplasma ixodetis in Ticks Removed from Humans, Sweden and Åland Islands, Finland
    M. Lager et al.
Research Letters
  • Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025
    N. Hassold-Rugolino et al.

    We report 2 cases of febrile lymphocytic meningitis with encephalitis in patients in France. One patient had not traveled outside Paris; the other had traveled to eastern France. Laboratory findings revealed acute West Nile virus infection. The cases occurred days apart, raising concern the virus has spread further in France.

  • Molecular Evidence of Dengue Virus Type 2 Emergence from Returning Travelers, Sinai Peninsula
    N. S. Zuckerman et al.
  • Human Infection with Avian Influenza A(H10N3) Virus, China, 2024
    J. Wang et al.

    We describe the clinical symptoms and epidemiologic characteristics of a patient infected with avian influenza A(H10N3) virus in Guangxi Province, China, in December 2024. Whole-genome sequencing showed that the virus was highly homologous to a virus from Yunnan Province. H10 subtype viruses should be monitored for potential zoonotic or reassortant events.

  • Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho
    K. J. Seung et al.
  • Emergence of Dengue Virus Serotype 3, Lineage III_B.3.2, Angola
    J. de Vasconcelos et al.
  • Fatal Tick-Borne Encephalitis in Unvaccinated Traveler from the United States to Switzerland, 2022
    C. Scotti et al.

    We report an unvaccinated traveler from the United States who contracted fulminant fatal tick-borne encephalitis while visiting Switzerland. Climate changes and international travel are intensifying tick exposure for unvaccinated persons. The increasing incidence of tick-borne encephalitis across Europe underscores the importance of tick bite prevention and vaccination against tick-borne encephalitis virus.

  • Orientia among Patients with Eschars and Suspected Tickborne Disease, North Carolina, 2020–2022
    H. A. Abernathy et al.
  • Yellow Fever Virus inAedes albopictus from an Urban Green Area in São Paulo State, Brazil
    E. S. Bergo et al.
  • Crimean-Congo Hemorrhagic Fever Virus in Cattle and Ticks, Israel
    N. Rudoler et al.

    We conducted a nationwide serologic and molecular survey to elucidate the epidemiologic status of Crimean-Congo hemorrhagic fever virus in Israel. We found serologic and molecular evidence of virus circulation in the country. Future human cases could be prevented by increasing public awareness and implementing public health measures.

  • Mortality Event in Rainbow Snakes Linked to Snake Fungal Disease, United States
    D. A. Conley et al.
  • Detection ofAedes (Fredwardsius)vittatus Mosquitoes, Yucatán Peninsula, Mexico, 2025
    R. J. Chan-Chable et al.

    We report detection ofAedes (Fredwardsius)vittatus mosquitoes in continental North America, in Yucatán, Mexico. Phylogenetic analysis clustered the sequence from mosquitoes collected in Mexico with Caribbean mosquito lineages, suggesting species introduction via the Caribbean. Given its arbovirus competence, urgent inclusion of theAe. vittatus mosquito in surveillance programs is warranted.

Etymologia

Top

Volume 31, Number 12—December 2025

Synopses
  • Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024–2025
    J. Cuéllar-Sáenz et al.
  • Two Concurrent Outbreaks ofListeria monocytogenes Infections Linked to Packaged Salads, 2014–2022
    A. Palacios et al.
Research
  • Group AStreptococcus Meningitis, United States, 1997–2022
    P. A. Hawkins et al.
  • Silent Propagation of Classical Scrapie Prions in Homozygous 222K Transgenic Mice, Europe
    N. Fernández-Borges et al.
  • Oral Transmission of Classical Bovine Spongiform Encephalopathy in ARR/ARR Sheep
    A. Huor et al.
  • Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020
    E. V. Kurbatova et al.
  • Guinea Pig Model for Lassa Virus Infection of Reproductive Tract and Considerations for Sexual and Vertical Transmission
    J. N. Seixas et al.
Dispatches
  • Healthcare Worker Attitudes and Perceptions toward Ebola Vaccine, United States, 2024
    R. Goswami et al.
  • Novel Highly Pathogenic Avian Influenza (A)H5N1 Triple Reassortant Virus, Argentina, 2025
    R. T. Vanstreels et al.
  • Hemophagocytic lymphohistiocytosis associated with West Nile virus infection: a case report
    C. Lascano et al.
  • Persistent Infection in Harbor Seals Years after Phocine Distemper Virus Epizootics
    M. van de Bildt et al.
  • Pancreatic Schistosomiasis in People’s Republic of China, 2020–2024
    L. He et al.
  • Case of Congenital Tularemia with Neuroinvasive Disease, Utah, USA
    B. D. Nelson et al.
  • Human Infection by Zoonotic Eye FlukePhilophthalmus lacrymosus, South America
    T. Weitzel et al.
  • Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Poultry Farm Workers, Washington, United States, 2024
    Y. Hatta et al.
  • Bat Reovirus as Cause of Acute Respiratory Disease and Encephalitis in Humans, Bangladesh, 2022–2023
    S. Sultana et al.
Research Letters
  • Wild and Domestic Animal Exposure Among Deceased Persons Referred for Organ Procurement, United States
    D. W. McCormick et al.
  • Metatranscriptomic Identification of Trubanaman Virus in Patient with Encephalitis, Australia
    K. Hajkowicz et al.
Online Report
  • Diphtheria Antitoxin Production and Procurement Practices and Challenges
    C. Marshall et al.

Top

Medscape, LLC is pleased to provide online continuing medical education (CME) for selected journal articles, allowing clinicians the opportunity to earn CME credit. In support of improving patient care, these activities have been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME credit is available for one year after publication.

Active CME Articles


Expires 9/23/2026
Medscape CME Activity
Reptile Exposure in Human Salmonellosis Cases andSalmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022 [PDF - 1.72 MB - 10 pages]
K. Paphitis et al.

Reptile-associated outbreaks of humanSalmonella infections are increasing in Canada, coinciding with a rise in the popularity of reptiles as pets. We conducted a retrospective analysis of surveillance data for humanSalmonella case-patients in Ontario during 2015–2022. We compared serotypes and reptile types for those reporting domestic reptile or amphibian exposure with veterinarySalmonella isolates reported during the same period. Case-patients commonly reported contact with reptile types from whichSalmonella was most frequently isolated. Some serotypes from human case-patients were closely associated with contact with specific reptile types, includingSalmonella Paratyphi B biovar Java (Salmonella Paratyphi B variant L (+) tartrate +) with snakes,Salmonella Agbeni with turtles, andSalmonella Cotham,Salmonella Chester, andSalmonella Tennessee with bearded dragons.Salmonella was most likely to be reported from reptiles fed a carnivorous diet. Education of reptile owners could help promote proper veterinary care and reduce transmission of zoonotic infections.

EIDPaphitis K, Reid A, Golightly HR, Adams JA, Corbeil A, Majury A, et al. Reptile Exposure in Human Salmonellosis Cases and Salmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022. Emerg Infect Dis. 2025;31(10):1912-1921. https://doi.org/10.3201/eid3110.241803
AMAPaphitis K, Reid A, Golightly HR, et al. Reptile Exposure in Human Salmonellosis Cases and Salmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022.Emerging Infectious Diseases. 2025;31(10):1912-1921. doi:10.3201/eid3110.241803.
APAPaphitis, K., Reid, A., Golightly, H. R., Adams, J. A., Corbeil, A., Majury, A....McClinchey, H. (2025). Reptile Exposure in Human Salmonellosis Cases and Salmonella Serotypes Isolated from Reptiles, Ontario, Canada, 2015–2022.Emerging Infectious Diseases,31(10), 1912-1921. https://doi.org/10.3201/eid3110.241803.

Expires 9/17/2026
Medscape CME Activity
Recent Systemic Antifungal Exposure and NonsusceptibleCandida in Hospitalized Patients, South Africa, 2012–2017 [PDF - 1.11 MB - 11 pages]
C. Rabault et al.

Candida bloodstream infections, and their increasing antifungal resistance, are a global concern. In this cross-sectional study, we analyzed 2,443 culture-confirmed candidemia cases reported in South Africa during 2012–2017 to assess the effect of previous antifungal exposure on nonsusceptibleCandida infection. We classified cases by species resistance profile and patient’s antifungal use within 14 days before infection. We found that 48% of cases were caused by nonsusceptible species, and 20% of patients had prior antifungal exposure, mainly to fluconazole. In patients >90 days of age, prior antifungal use was significantly associated with nonsusceptibleCandida bloodstream infection (adjusted OR 2.02, 95% CI 1.43–2.87; p<0.001), with species-specific effects. No such association was found in neonates and young infants, for whom hospital transmission appeared more influential. Our findings underscore the need for targeted antifungal stewardship and enhanced infection prevention to mitigate antifungal resistance in South Africa.

EIDRabault C, Shuping L, Mpembe R, Quan V, Lanternier F, Lortholary O, et al. Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012–2017. Emerg Infect Dis. 2025;31(10):1901-1911. https://doi.org/10.3201/eid3110.250359
AMARabault C, Shuping L, Mpembe R, et al. Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012–2017.Emerging Infectious Diseases. 2025;31(10):1901-1911. doi:10.3201/eid3110.250359.
APARabault, C., Shuping, L., Mpembe, R., Quan, V., Lanternier, F., Lortholary, O....Govender, N. P. (2025). Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012–2017.Emerging Infectious Diseases,31(10), 1901-1911. https://doi.org/10.3201/eid3110.250359.

Expires 8/22/2026
Medscape CME Activity
Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda [PDF - 1.22 MB - 10 pages]
P. W. Blair et al.

The complexity of rickettsial serodiagnostics during acute illness has limited clinical characterization in Africa. We used archived samples from sepsis (n = 259) and acute febrile illness (n = 70) cohorts in Uganda to identify spotted fever and typhus group rickettsiae by using immunofluorescence assay and clinically validated rRNA reverse transcription PCR (RT-PCR). Among 329 participants, 10.0% had rickettsial infections (n = 33; n = 20 identified with immunofluorescence assay and n = 13 by RT-PCR). Serum rRNA RT-PCR was 75.0% (95% CI 42.8–94.5%) sensitive and 91.2% (95% CI 85.8–95.1%) specific. Thrombocytopenia was more common among patients with rickettsial infections than with other nonmalarial infections (adjusted odds ratio 3.7; p = 0.003). No participants were on a tetracycline antimicrobial drug at admission. rRNA RT-PCR is a promising diagnostic strategy for identifying acute rickettsial infections. Doxycycline should be included in empiric antimicrobial drug regimens for nonmalarial febrile illness in this region.

EIDBlair PW, Alharthi S, Londoño AF, Wailagala A, Manabe YC, Dumler J. Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda. Emerg Infect Dis. 2025;31(9):1708-1717. https://doi.org/10.3201/eid3109.250479
AMABlair PW, Alharthi S, Londoño AF, et al. Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda.Emerging Infectious Diseases. 2025;31(9):1708-1717. doi:10.3201/eid3109.250479.
APABlair, P. W., Alharthi, S., Londoño, A. F., Wailagala, A., Manabe, Y. C., & Dumler, J. (2025). Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda.Emerging Infectious Diseases,31(9), 1708-1717. https://doi.org/10.3201/eid3109.250479.

Expires 8/21/2026
Medscape CME Activity
Severe Group AStreptococcus Infection among Children, France, 2022–2024 [PDF - 1.01 MB - 10 pages]
M. Colomina et al.
Suggested citation for this article

Sierra Colomina M, Flamant A, Le Balle G, Cohen JF, Berthomieu L, Leteurtre S, et al. Severe group AStreptococcus infection among children, France, 2022–2024. Emerg Infect Dis. 2025 Sep [date cited].https://doi.org/10.3201/eid3109.250245

Group AStreptococcus infections have increased in Europe since September 2022. The French Pediatric Intensive Care and French Pediatric Infectious Diseases expert groups conducted a retrospective and prospective study of children who had severe group AStreptococcus infections during September 1, 2022–April 1, 2024, across 34 hospitals in France. A total of 402 pediatric patients (median age 4 [interquartile range 2–7.5] years; 42% girls, 58% boys) were enrolled. Cases were characterized by a low proportion of severe skin and soft tissue infections (16%), predominance of severe upper and lower respiratory tract infections (55%), and a 3.5% case-fatality rate. In multivariate analysis, hydrocortisone, corticosteroid, and vasopressor therapies were significantly associated with major sequelae or death. Molecular analysis revealedemm1 (73.0%) andemm12 (10.8%) strains; the M1UK clone represented 50% ofemm1 strains. Clinicians, researchers, and public health authorities must collaborate to mitigate the effects of GAS on child health.

EIDColomina M, Flamant A, Le Balle G, Cohen JF, Berthomieu L, Leteurtre S, et al. Severe Group A Streptococcus Infection among Children, France, 2022–2024. Emerg Infect Dis. 2025;31(9):1698-1707. https://doi.org/10.3201/eid3109.250245
AMAColomina M, Flamant A, Le Balle G, et al. Severe Group A Streptococcus Infection among Children, France, 2022–2024.Emerging Infectious Diseases. 2025;31(9):1698-1707. doi:10.3201/eid3109.250245.
APAColomina, M., Flamant, A., Le Balle, G., Cohen, J. F., Berthomieu, L., Leteurtre, S....Brehin, C. (2025). Severe Group A Streptococcus Infection among Children, France, 2022–2024.Emerging Infectious Diseases,31(9), 1698-1707. https://doi.org/10.3201/eid3109.250245.

Expires 7/24/2026
Medscape CME Activity
Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020–2024 [PDF - 1.42 MB - 11 pages]
K. Jabeen et al.

Prevalence of emerging fungal infections is increasing, particularly among immunocompromised persons, children, and older persons. We report 108 cases ofScheffersomyces spartinae infection in pediatric patients from Karachi and other cities in Pakistan, of which 107 were identified from blood cultures. Cultures were initially misidentified asClavispora lusitaniae by a biochemical assay before speciation asS. spartinae by whole-genome sequencing. All isolates were from children<12 years of age, and >69% were from children <1 month of age. Isolates were genetically distinct across regions of Pakistan; however, genetic diversity was low in isolates from patients in Karachi and nearby Nawabshah and had median differences of just 9 pairwise nucleotide variants. This study demonstratesS. spartinae is a potentially emerging pathogen in neonates and young infants in Pakistan. The findings highlight the limitations of phenotypic identification for detecting emerging fungal infections and underscore the value of molecular identification approaches.

EIDJabeen K, Farooqi J, Simons LM, Hultquist JF, Lorenzo-Redondo R, Evans CT, et al. Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020–2024. Emerg Infect Dis. 2025;31(8):1550-1560. https://doi.org/10.3201/eid3108.241604
AMAJabeen K, Farooqi J, Simons LM, et al. Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020–2024.Emerging Infectious Diseases. 2025;31(8):1550-1560. doi:10.3201/eid3108.241604.
APAJabeen, K., Farooqi, J., Simons, L. M., Hultquist, J. F., Lorenzo-Redondo, R., Evans, C. T....Ozer, E. A. (2025). Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020–2024.Emerging Infectious Diseases,31(8), 1550-1560. https://doi.org/10.3201/eid3108.241604.

Expires 7/23/2026
Medscape CME Activity
Emergence of Clade Ib Monkeypox Virus—Current State of Evidence [PDF - 1.99 MB - 10 pages]
P. S. Satheshkumar et al.

Mpox was first identified against the backdrop of the smallpox eradication campaign. Monkeypox virus (MPXV), the causative agent of mpox, has been maintained in animal reservoirs in the forested regions of West and Central Africa as 2 distinct clades; clade I has historically caused more severe infection in Central Africa than clade II, historically found in West Africa. However, rapid reemergence and spread of both MPXV clades through novel routes of transmission have challenged the known characteristics of mpox. We summarize mpox demographic distribution, clinical severity, and case-fatality rates attributed to genetically distinct MPXV subclades and focus on MPXV clade Ib, the more recently identified subclade. Broad worldwide assistance will be necessary to halt the spread of both MPXV clades within mpox endemic and nonendemic regions to prevent future outbreaks.

EIDSatheshkumar PS, Gigante CM, Mbala-Kingebeni P, Nakazawa Y, Anderson M, Balinandi S, et al. Emergence of Clade Ib Monkeypox Virus—Current State of Evidence. Emerg Infect Dis. 2025;31(8):1516-1525. https://doi.org/10.3201/eid3108.241551
AMASatheshkumar PS, Gigante CM, Mbala-Kingebeni P, et al. Emergence of Clade Ib Monkeypox Virus—Current State of Evidence.Emerging Infectious Diseases. 2025;31(8):1516-1525. doi:10.3201/eid3108.241551.
APASatheshkumar, P. S., Gigante, C. M., Mbala-Kingebeni, P., Nakazawa, Y., Anderson, M., Balinandi, S....Hutson, C. L. (2025). Emergence of Clade Ib Monkeypox Virus—Current State of Evidence.Emerging Infectious Diseases,31(8), 1516-1525. https://doi.org/10.3201/eid3108.241551.

Expires 6/23/2026
Medscape CME Activity
Multicenter Case–Control Study of Behavioral, Environmental, and Geographic Risk Factors for Talaromycosis, Vietnam [PDF - 829 KB - 10 pages]
L. Brown et al.

Talaromycosis is a life-threatening fungal disease that primarily affects immunocompromised persons in Southeast Asia. We conducted a multicenter, case–control study recruiting participants with advanced HIV disease in Vietnam; 205 case-patients with culture-confirmed talaromycosis were matched to 405 control-patients by age, sex, and CD4 count. Occupational exposure to tropical plants (odds ratio [OR] 1.73 [95% CI 1.10–2.73]; p = 0.017) and to farmed animals (OR 2.07 [95% CI 1.20–3.55]; p = 0.009) were independent risk factors for talaromycosis. Talaromycosis risk was higher in participants from highland regions than in persons from lowland regions (p<0.05). Participants from lowland regions who had lived or traveled to highland regions had a higher risk for talaromycosis (OR 3.15 [95% CI 1.49–6.64]; p = 0.003). This study confirms the epidemiologic correlation between talaromycosis and soil exposure and demonstrates an epidemiologic link between talaromycosis and residence in or travel to highland regions of Vietnam.

EIDBrown L, Jonat B, Ly V, Tung N, Lam PS, Thanh N, et al. Multicenter Case–Control Study of Behavioral, Environmental, and Geographic Risk Factors for Talaromycosis, Vietnam. Emerg Infect Dis. 2025;31(7):1309-1318. https://doi.org/10.3201/eid3107.250143
AMABrown L, Jonat B, Ly V, et al. Multicenter Case–Control Study of Behavioral, Environmental, and Geographic Risk Factors for Talaromycosis, Vietnam.Emerging Infectious Diseases. 2025;31(7):1309-1318. doi:10.3201/eid3107.250143.
APABrown, L., Jonat, B., Ly, V., Tung, N., Lam, P. S., Thanh, N....Le, T. (2025). Multicenter Case–Control Study of Behavioral, Environmental, and Geographic Risk Factors for Talaromycosis, Vietnam.Emerging Infectious Diseases,31(7), 1309-1318. https://doi.org/10.3201/eid3107.250143.

Expires 5/28/2026
Medscape CME Activity
Multicenter Retrospective Study ofSpiroplasma ixodetis Infantile Cataract in 8 Countries in Europe [PDF - 1.43 MB - 9 pages]
L. Van Os et al.

Spiroplasma ixodetis has been reported to cause the rare combination of cataract and uveitis in infants. Through a retrospective analysis of available literature and additional unpublished cases, we identified 28 eyes from 18 infants from 8 countries in Europe with cataracts and intraocular inflammation. The cataracts were bilateral in 55.6%, unilateral in 44.4%, and progressive in 46.4% of patients. Granulomatous anterior uveitis was found in all infants. Presence ofS. ixodetis was supported by PCR (positive in 89.3% of eyes tested), transmission electron microscopy (positive in 90% of eyes tested), or culture of aspirated lens material (positive in 87.5% of eyes tested). Treatment with macrolide antimicrobial drugs, corticosteroids, and lensectomy appeared to be effective. Two patients had a recurrence of the uveitis after lens extraction and needed prolonged treatment. To increase awareness ofS. ixodetis, we suggest its inclusion with the organisms of the TORCH acronym.

EIDVan Os L, Cassoux N, Cholidis S, Dureau P, Farassat N, Fierz F, et al. Multicenter Retrospective Study of Spiroplasma ixodetis Infantile Cataract in 8 Countries in Europe. Emerg Infect Dis. 2025;31(6):1081-1089. https://doi.org/10.3201/eid3106.240954
AMAVan Os L, Cassoux N, Cholidis S, et al. Multicenter Retrospective Study of Spiroplasma ixodetis Infantile Cataract in 8 Countries in Europe.Emerging Infectious Diseases. 2025;31(6):1081-1089. doi:10.3201/eid3106.240954.
APAVan Os, L., Cassoux, N., Cholidis, S., Dureau, P., Farassat, N., Fierz, F....Lorenz, B. (2025). Multicenter Retrospective Study of Spiroplasma ixodetis Infantile Cataract in 8 Countries in Europe.Emerging Infectious Diseases,31(6), 1081-1089. https://doi.org/10.3201/eid3106.240954.

Expires 5/27/2026
Medscape CME Activity
Clinical Manifestations, Risk Factors, and Disease Burden of Rickettsiosis, Cambodia, 2007–2020 [PDF - 1.70 MB - 12 pages]
G. C. Kelly et al.

During 2007–2020, we conducted a cross-sectional prevalence study among patients with acute undifferentiated febrile illness to describe the burden and long-term epidemiology of rickettsioses in Cambodia. Serum samples were collected from 10,243 participants, along with epidemiologic data, information on clinical symptoms, demographic characteristics, and risk factors. A total of 802 (7.8%) participants met the definition for acute rickettsial infection after ruling out malaria, influenza, dengue, and chikungunya; 557 (5.4%) cases were typhus, 154 (1.5%) spotted fever, and 136 (1.3%) scrub typhus. Overall seroprevalence was 18.1% (1,857/10,243). Increased age, residence in urban settings, and recent travel to forests were significantly associated with rickettsial infection. Symptoms significantly associated with infection included rash, vomiting, and skin lesions. Our results confirm the underlying burden of rickettsioses and associated risk factors in Cambodia and highlight the need for accessible diagnostics and clinical guidance that consider rickettsioses when treating persons with acute undifferentiated febrile illness.

EIDKelly GC, Rachmat A, Tran L, Supaprom C, Phireak H, Prom S, et al. Clinical Manifestations, Risk Factors, and Disease Burden of Rickettsiosis, Cambodia, 2007–2020. Emerg Infect Dis. 2025;31(6):1069-1080. https://doi.org/10.3201/eid3106.241752
AMAKelly GC, Rachmat A, Tran L, et al. Clinical Manifestations, Risk Factors, and Disease Burden of Rickettsiosis, Cambodia, 2007–2020.Emerging Infectious Diseases. 2025;31(6):1069-1080. doi:10.3201/eid3106.241752.
APAKelly, G. C., Rachmat, A., Tran, L., Supaprom, C., Phireak, H., Prom, S....Letizia, A. G. (2025). Clinical Manifestations, Risk Factors, and Disease Burden of Rickettsiosis, Cambodia, 2007–2020.Emerging Infectious Diseases,31(6), 1069-1080. https://doi.org/10.3201/eid3106.241752.

Expires 4/29/2026
Medscape CME Activity
Features of Invasive Aspergillosis Caused byAspergillus flavus, France, 2012–2018 [PDF - 590 KB - 10 pages]
L. Bertin-Biasutto et al.

Invasive aspergillosis (IA) caused byAspergillus flavus remains poorly described. We retrospectively analyzed 54 cases of IA caused byA. flavus reported in France during 2012–2018. Among cases, underlying IA risk factors were malignancy, solid organ transplantation, and diabetes. Most (87%, 47/54) infections were localized, of which 33 were pleuropulmonary and 13 were ear-nose-throat (ENT) infection sites. Malignancy (70% [23/33]) and solid organ transplantation (21% [7/33]) were the main risk factors in localized pulmonary infections, and diabetes mellitus was associated with localized ENT involvement (61.5%, [8/13]). Fungal co-infections were frequent in pulmonary (36%, 12/33) but not ENT IA (0 cases). Antifungal monotherapy was prescribed in 45/50 (90%) cases, mainly voriconazole (67%, 30/45). All-cause 30-day case-fatality rates were 39.2% and 90-day rates were 47.1%, and rates varied according to risk factor, IA site, and fungal co-infections. Clinicians should remain vigilant forA. flavus and consider it in the differential diagnosis for IA.

EIDBertin-Biasutto L, Paccoud O, Garcia-Hermoso D, Denis B, Boukris-Sitbon K, Lortholary O, et al. Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012–2018. Emerg Infect Dis. 2025;31(5):896-905. https://doi.org/10.3201/eid3105.241392
AMABertin-Biasutto L, Paccoud O, Garcia-Hermoso D, et al. Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012–2018.Emerging Infectious Diseases. 2025;31(5):896-905. doi:10.3201/eid3105.241392.
APABertin-Biasutto, L., Paccoud, O., Garcia-Hermoso, D., Denis, B., Boukris-Sitbon, K., Lortholary, O....Lanternier, F. (2025). Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012–2018.Emerging Infectious Diseases,31(5), 896-905. https://doi.org/10.3201/eid3105.241392.

Expires 4/22/2026
Medscape CME Activity
Nationwide Observational Case–Control Study of Risk Factors forAerococcus Bloodstream Infections, Sweden [PDF - 1.42 MB - 12 pages]
J. Walles et al.

Risk factors for developing bloodstream infections (BSIs) caused byAerococcus bacteria remain insufficiently examined. In this nationwide case–control study in Sweden, 19 of 23 clinical microbiological laboratories identified patients who had aerococcal BSIs during 2012–2016. We compared each of those index patients with 4 controls matched for age, sex, and county of residence. Overall, 588 episodes of aerococcal BSI occurred over 39.6 million person-years, corresponding to an average incidence of 1.48/100,000 person-years (95% CI 1.37–1.60/100,000 person-years). Most infections developed in men >65 years of age. Aerococcal BSI was associated with neurologic (adjusted odds ratio 2.89 [95% CI 2.26–3.70]) and urologic (adjusted odds ratio 2.15 [95% CI 1.72—2.68]) conditions and previous hospitalization or infection treatment. Our findings support the previously observed predilection for aerococcal BSIs developing in elderly men with urinary tract disorders. Awareness ofAerococcus spp. in patients, especially elderly men, will be needed to manage invasive infections.

EIDWalles J, Inghammar M, Rasmussen M, Sunnerhagen T. Nationwide Observational Case–Control Study of Risk Factors for Aerococcus Bloodstream Infections, Sweden. Emerg Infect Dis. 2025;31(5):917-928. https://doi.org/10.3201/eid3105.240424
AMAWalles J, Inghammar M, Rasmussen M, et al. Nationwide Observational Case–Control Study of Risk Factors for Aerococcus Bloodstream Infections, Sweden.Emerging Infectious Diseases. 2025;31(5):917-928. doi:10.3201/eid3105.240424.
APAWalles, J., Inghammar, M., Rasmussen, M., & Sunnerhagen, T. (2025). Nationwide Observational Case–Control Study of Risk Factors for Aerococcus Bloodstream Infections, Sweden.Emerging Infectious Diseases,31(5), 917-928. https://doi.org/10.3201/eid3105.240424.

Expires 3/21/2026
Medscape CME Activity
Epidemiology of Tularemia among Humans and Animals, Baden-Wuerttemberg, Germany, 2012–2022 [PDF - 1.43 MB - 11 pages]
S. Nothdurfter et al.

Tularemia, a zoonosis caused byFrancisella tularensis, is endemic in Baden-Wuerttemberg, Germany. To determine tularemia epidemiology in this region, we characterized the genetic diversity ofF. tularensis in human and animal isolates during 2012–2022 by using whole-genome sequencing, combined with human and veterinary surveillance data analysis. Human case numbers varied; most cases occurred in 2021 (n = 34). Arthropod bites were reported most in cases with information on animal exposure (45%, n = 43). Poisson regression confirmed a significant increase in human cases during the study period (p<0.001). No seasonal pattern was identified, but case numbers were lowest in winter. Human surveillance data often lacked exposure details. Positivity rates in animals were 5%–34%, increasing since 2017. Human isolates often clustered with hare-derived strains, although transmission routes often remain unclear. These findings emphasize the importance of combining genome sequencing with detailed epidemiologic tracing to identify infection sources and improve surveillance data.

EIDNothdurfter S, Linde J, Sting R, Tomaso H, Heuner K, Meincke M, et al. Epidemiology of Tularemia among Humans and Animals, Baden-Wuerttemberg, Germany, 2012–2022. Emerg Infect Dis. 2025;31(4):678-688. https://doi.org/10.3201/eid3104.240414
AMANothdurfter S, Linde J, Sting R, et al. Epidemiology of Tularemia among Humans and Animals, Baden-Wuerttemberg, Germany, 2012–2022.Emerging Infectious Diseases. 2025;31(4):678-688. doi:10.3201/eid3104.240414.
APANothdurfter, S., Linde, J., Sting, R., Tomaso, H., Heuner, K., Meincke, M....Wagner-Wiening, C. (2025). Epidemiology of Tularemia among Humans and Animals, Baden-Wuerttemberg, Germany, 2012–2022.Emerging Infectious Diseases,31(4), 678-688. https://doi.org/10.3201/eid3104.240414.

Expires 2/24/2026
Medscape CME Activity
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes [PDF - 985 KB - 10 pages]
E. V. Kurbatova et al.

A previous study demonstrated noninferior efficacy of 4-month rifapentine/moxifloxacin regimen for tuberculosis (TB) treatment compared with the standard regimen. We explored results among study participants with diabetes. Among 2,516 randomized participants, 181 (7.2%) had diabetes. Of 166 participants with diabetes in the microbiologically eligible analysis group, 26.3% (15/57) had unfavorable outcomes in the control regimen, 13.8% (8/58) in the rifapentine/moxifloxacin regimen, and 29.4% (15/51) in the rifapentine regimen. The difference in proportion of unfavorable outcomes between the control and rifapentine/moxifloxacin arms in the microbiologically eligible analysis group was –12.5% (95% CI –27.0% to 1.9%); the difference between the control and rifapentine arms was 3.1% (95% CI –13.8% to 20.0%). Safety outcomes were similar in the rifapentine/moxifloxacin regimen and control arms. Among participants with TB and diabetes, the rifapentine/moxifloxacin arm had fewest unfavorable outcomes and was safe. Our findings indicate that the rifapentine/moxifloxacin regimen can be used in persons with TB and diabetes.

EIDKurbatova EV, Whitworth WC, Peddareddy L, Phillips P, Scott NA, Bryant KE, et al. Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes. Emerg Infect Dis. 2025;31(3):467-476. https://doi.org/10.3201/eid3103.241634
AMAKurbatova EV, Whitworth WC, Peddareddy L, et al. Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.Emerging Infectious Diseases. 2025;31(3):467-476. doi:10.3201/eid3103.241634.
APAKurbatova, E. V., Whitworth, W. C., Peddareddy, L., Phillips, P., Scott, N. A., Bryant, K. E....Nguyen, N. V. (2025). Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.Emerging Infectious Diseases,31(3), 467-476. https://doi.org/10.3201/eid3103.241634.

Expires 1/23/2026
Medscape CME Activity
National Surveillance of Human Ehrlichiosis Caused byEhrlichia ewingii, United States, 2013–2021 [PDF - 652 KB - 6 pages]
S. N. Adams et al.

Human ehrlichiosis is a potentially fatal tickborne disease caused by 3 species:Ehrlichia chaffeensis,E. ewingii, andE. muris eauclairensis. In the United States, 234 confirmed cases ofE. ewingii ehrlichiosis were reported to the Centers for Disease Control and Prevention through the National Notifiable Diseases Surveillance System during 2013–2021; average annual incidence was 0.08 cases/1 million population.E. ewingii ehrlichiosis was reported more commonly among older, White, non-Hispanic, and male patients. Incidence and case counts generally increased yearly, except for 2020 and 2021. The highest number of cases were reported from Missouri and Arkansas. We report the geographic expansion ofE. ewingii ehrlichiosis and the continued public health challenge of clarifying clinical manifestations of this infection. Clinician education will be essential to implement molecular assays to properly diagnoseE. ewingii infection in patients and gain a better understanding of the epidemiology of this emerging disease.

EIDAdams SN, Bestul NC, Calloway KN, Kersh GJ, Salzer JS. National Surveillance of Human Ehrlichiosis Caused by Ehrlichia ewingii, United States, 2013–2021. Emerg Infect Dis. 2025;31(2):222-227. https://doi.org/10.3201/eid3102.240279
AMAAdams SN, Bestul NC, Calloway KN, et al. National Surveillance of Human Ehrlichiosis Caused by Ehrlichia ewingii, United States, 2013–2021.Emerging Infectious Diseases. 2025;31(2):222-227. doi:10.3201/eid3102.240279.
APAAdams, S. N., Bestul, N. C., Calloway, K. N., Kersh, G. J., & Salzer, J. S. (2025). National Surveillance of Human Ehrlichiosis Caused by Ehrlichia ewingii, United States, 2013–2021.Emerging Infectious Diseases,31(2), 222-227. https://doi.org/10.3201/eid3102.240279.

Expires 1/22/2026
Medscape CME Activity
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England [PDF - 1.08 MB - 9 pages]
M. A. Davies et al.

A global increase in the incidence of invasive group AStreptococcus (iGAS) infections was observed after lifting of COVID-19 related restrictions in 2022, and type M1UK dominated in many countries. After seasonal declines in iGAS incidence during the summer of 2023, simultaneous, rapid expansion of a previously rareemm type 3.93 was seen beginning in November, increasing to 20% of all cases in England and 60% of all cases in the Netherlands within 4 months.emm3.93 was associated with iGAS in children 6–17 years of age and with increased risk for pneumonia or pleural empyema and meningitis in both countries. No excess risk of death was identified foremm3.93 compared with other types. Genomic analysis of historic and contemporaryemm3.93 isolates revealed the emergence of 3 new clades with a potentially advantageous genomic configuration. Our findings demonstrate the value of molecular surveillance, including long-read sequencing, in identifying clinical and public health threats.

EIDDavies MA, de Gier B, Guy RL, Coelho J, van Dam AP, van Houdt R, et al. Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England. Emerg Infect Dis. 2025;31(2):229-236. https://doi.org/10.3201/eid3102.240880
AMADavies MA, de Gier B, Guy RL, et al. Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England.Emerging Infectious Diseases. 2025;31(2):229-236. doi:10.3201/eid3102.240880.
APADavies, M. A., de Gier, B., Guy, R. L., Coelho, J., van Dam, A. P., van Houdt, R....van Sorge, N. M. (2025). Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England.Emerging Infectious Diseases,31(2), 229-236. https://doi.org/10.3201/eid3102.240880.

Expires 12/20/2025
Medscape CME Activity
Rickettsia sibirica mongolitimonae Infections in Spain and Case Review of the Literature [PDF - 1.50 MB - 9 pages]
S. Santibáñez et al.

Rickettsia sibirica mongolitimonae is an emerging cause of tickborne rickettsiosis. Since the bacterium was first documented as a human pathogen in 1996, a total of 69 patients with this infection have been reported in the literature. Because of the rising rate ofR. sibirica mongolitimonae infection cases, we evaluated the epidemiologic and clinical features of 29 patients who hadR. sibirica mongolitimonae infections confirmed during 2007–2024 at the Center for Rickettsiosis and Arthropod-Borne Diseases, the reference laboratory of San Pedro University Hospital–Center for Biomedical Research of La Rioja, Logroño, Spain. We also reviewed all cases published in the literature during 1996–2024, evaluating features of 94 cases ofR. sibirica mongolitimonae infection (89 in Europe, 4 in Africa, and 1 in Asia). Clinicians should considerR. sibirica mongolitimonae as a potential causative agent of rickettsiosis, and doxycycline should be administered promptly to avoid clinical complications.

EIDSantibáñez S, Ramos-Rincón J, Santibáñez P, Cervera-Acedo C, Sanjoaquín I, de Arellano E, et al. Rickettsia sibirica mongolitimonae Infections in Spain and Case Review of the Literature. Emerg Infect Dis. 2025;31(1):18-26. https://doi.org/10.3201/eid3101.240151
AMASantibáñez S, Ramos-Rincón J, Santibáñez P, et al. Rickettsia sibirica mongolitimonae Infections in Spain and Case Review of the Literature.Emerging Infectious Diseases. 2025;31(1):18-26. doi:10.3201/eid3101.240151.
APASantibáñez, S., Ramos-Rincón, J., Santibáñez, P., Cervera-Acedo, C., Sanjoaquín, I., de Arellano, E....Oteo, J. A. (2025). Rickettsia sibirica mongolitimonae Infections in Spain and Case Review of the Literature.Emerging Infectious Diseases,31(1), 18-26. https://doi.org/10.3201/eid3101.240151.

Expires 12/19/2025
Medscape CME Activity
Pneumococcal Septic Arthritis among Adults, France, 2010–2018 [PDF - 839 KB - 10 pages]
F. Hamdad et al.

Streptococcus pneumoniae infection is considered an uncommon cause of arthritis in adults. To determine the clinical and microbiological characteristics of pneumococcal septic arthritis, we retrospectively studied a large series of cases among adult patients during the 2010–2018 conjugate vaccine era in France. We identified 110 patients (56 women, 54 men; mean age 65 years), and cases included 82 native joint infections and 28 prosthetic joint infections. Most commonly affected were the knee (50/110) and hip (25/110). Concomitant pneumococcal infections were found in 37.2% (38/102) and bacteremia in 57.3% (55/96) of patients, and underlying conditions were noted for 81.4% (83/102). Mortality rate was 9.4% (8/85). The proportion of strains not susceptible to penicillin was 29.1% (32/110). Of the 55 serotyped strains, 31 (56.4%) were covered by standard pneumococcal vaccines; however, several nonvaccine serotypes (mainly 23B, 24F, and 15A) had emerged, for which susceptibility to β-lactams was low.

EIDHamdad F, El Bayeh N, Auger G, Peuchant O, Wallet F, Ruimy R, et al. Pneumococcal Septic Arthritis among Adults, France, 2010–2018. Emerg Infect Dis. 2025;31(1):8-17. https://doi.org/10.3201/eid3101.240321
AMAHamdad F, El Bayeh N, Auger G, et al. Pneumococcal Septic Arthritis among Adults, France, 2010–2018.Emerging Infectious Diseases. 2025;31(1):8-17. doi:10.3201/eid3101.240321.
APAHamdad, F., El Bayeh, N., Auger, G., Peuchant, O., Wallet, F., Ruimy, R....Cattoir, V. (2025). Pneumococcal Septic Arthritis among Adults, France, 2010–2018.Emerging Infectious Diseases,31(1), 8-17. https://doi.org/10.3201/eid3101.240321.

Page created: September 25, 2025
Page updated: September 25, 2025
Page reviewed: September 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

Connect and Share
Additional CDC Resources
file_external

Article Quick Search

Help
Enter search terms into the textbox above and click "Search" to seach all articles in the journal. The search must be at least three characters long.

To search for exact phrases, use quotation marks around the words that should be grouped together.

This search feature is powered by PubMed Central and uses an algorithm to rank the most relevant results. Search results are limited to the first 200 results.

[8]ページ先頭

©2009-2025 Movatter.jp